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Sympathetic 
manifestation of 
CHAPTER I 
INTRODUCTION 
nervous system activation is accepted as a general 
circulatory shock. While early increases in 
sympathetic drive support the cardiovascular and metabolic adaptations 
to these stressful stimuli, excessive periods of increased sympathetic 
activity are considered detrimental, and contribute to the development 
of irreversibility. Indeed, blunting the actions of the sympathetic 
nervous system has beneficial effects in the outcome of circulatory 
shock. More specifically, protection with adrenergic blockade has been 
demonstrated in sepsis, both clinically and in various experimental 
models including endotoxin 
·hyperacti vation is, therefore, 
pathogenesis of endotoxin shock. 
One critical issue 
shock. 
considered 
Inappropriate sympathetic 
a major factor in the 
regarding sympathetic nervous system 
activation in endotoxin shock is the methodology employed to quantitate 
nerve activity. Most demon~trations of increased sympathetic activity 
have been indirect in nature. These include increased circulating 
concentrations of norepinephrine and epinephrine as well as decreased 
tissue content of both bioamines. Interpretations of indirect 
neurochemical indices are limited. Neither marker of the sympathetic 
nervous system, i.e. circulating or tissue content of norepin~phrine, 
2 
can adequately quantitate sympathetic activity. Furthermore, increased 
circulating norepinephrine may be due to reduced neuronal reuptake or 
decreased peripheral catabolism of the bioamine rather than increased 
sympathetic nerve activity. Depletion of peripheral tissue 
norepinephrine may be caused by inhibition of biosynthesis, decreased 
neuronal 
augmented 
activity 
reuptake, or increased intraneuronal catabolism rather than 
sympathetic nerve activation. Electronic recording of nerve 
provides a direct and quantitative assessment of sympathetic 
function. However, nerve recording requires invasive procedures on 
anesthetized animals and has provided conflicting results when applied 
to endotoxic models. Thus, although extensive work has implicated the 
sympathetic nervous system in the pathogenesis of endotoxin shock, few 
experiments have directly and quantitatively assessed sympathetic 
activity. 
Two key, related aspects of sympathetic activation during 
endotoxin shock raise a second important issue. One is that 
norepinephrine depletion from tissues occurs during shock; a second is 
that blocking sympathetic activity is beneficial during endotoxic shock. 
Therefore, the depletion of norepinephrine transfers excessive amounts 
of the bioamine to areas accessible to adrenergic receptors, enhancing 
the effective sympathetic stimulation of the whole animal. Description 
of the characteristcs of the depletion and elucidation of the underlying 
mechanisms causing it are key issues to address if sympathetic 
dysfunction in endotoxin shock is to be understood and reversed." It may 
then be possible to apply the findings from experimental studies of 
endotoxic 
3 
shock to its clinical counterpart, and facilitate the 
management of sepsis. 
Therefore, this dissertation: 1) describes the scientific 
evidence implicating the sympathetic nervous system in the pathogenesis 
of endotoxin shock, 2) reviews the normal mechanisms involved in 
maintenance of tissue catecholamine stores and the information known 
about the pathologic features of norepinephrine depletion in circulatory 
shock, 3) develops a logical approach to investigate sympathetic 
dysfunction in endotoxic shock, 4) presents findings pertinent to the 
questions raised, and 5) relates the present results to the existing 
literature. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
A. Evidence for Sympathetic Activation in Endotoxin Shock 
As outlined in the introduction, the sympathetic nervous system 
has been implicated in the pathogenesis of endotoxin shock. Although 
the demonstrations of sympathetic activity have been convincing, the 
methodologies employed have been qualitative and indirect in nature. 
Essentially four lines of investigation have provided evidence for 
sympathetic activation during endotoxin shock: 1) demonstration of 
increased plasma catecholamine concentrations, 2) depletion of tissue 
catecholamine stores, 3) radioisotopic experiments that traced the fate 
of injected radiolabeled catecholamines, and 4) direct 
electrophysiologic measurement of nerve activity. Each of these four 
areas will be reviewed in the following sections. 
1. ELEVATION OF PLASMA CATECHOLAMINES 
Plasma catecholamines have been measured in a variety of 
endotoxic models. Various results have been reported. In some models a 
singular rise in plasma epinephrine has been demonstrated. Spink!..! al. 
(142) measured femoral arterial catecholamine concentrations in five 
groups of endotoxic dogs. Increasing doses of endotoxin (Group I) 
4 
5 
resulted in progressive increases in plasma epinephrine, but only a 
minimal increase of norepinephrine at the highest dose (2 mg/kg). The 
rate of endotoxin infusion (Group II) had the effect of raising 
epinephrine levels minimally. Rapid infusion of an endotoxin dose 
produced greater plasma epinephrine levels than slow infusion at only 
one time point (one hour) after infusion even though rapid infusion 
resulted in a 50% per cent higher lethality than slow infuson. Dogs 
tolerant to endotoxin (Group III; surviving an initial dose 3 weeks 
previously) demonstrated lower lethality than non-tolerant dogs, but 
both groups showed the same plasma epinephrine levels. Adrenalectomy 
(Group IV) or complete cervical spinal cord section (Group V) sensitized 
the dogs to endotoxin. The procedures also totally eliminated the 
elevated plasma epinephrine associated with endotoxin infusion. Thus, 
the experiments showed that endotoxin caused a selective increase in 
plasma epinephrine that was dose-dependent and neurally-mediated. The 
catecholamine response was subsequently shown by the same group of 
investigators to be more pronounced in puppies (124). Nykiel and 
Glaviano (112) in studies on anesthetized endotoxic dogs reported 
similar results. The experimental model was different to some extent. 
Blood was 
function. 
sampled 
The 
from the 
results 
adrenal vein to assess adrenal medullary 
indicated that epinephrine, but not 
norepinephrine was increased in adrenal venous blood of endotoxic 
animals. 
decreased 
response 
The increased epinephrine occurred only in the presence of 
arterial blood pressure. Additionally, the 
was eliminated by section of the splanchnic nerves. 
epinephrine 
Thus, the 
6 
increase in plasma catecholamines was again shown to be dependent on 
nerve activation. 
Further investigation of adrenal medullary contribution to 
circulating catecholamines has been performed. Egdahl (35,36) studied 
the differential effects of endotoxin on adrenal medullary and cortical 
function in the dog. Adrenal venous blood was collected from indwelling 
catheters in unanesthetized dogs and analyzed for total catecholamines 
and 17-hydroxycorticosteroids to assess medullary and cortical function, 
respectively. Low doses of endotoxin (0.01 mg/dog) stimulated adrenal 
cortical secretion and fever but infrequently led to increased 
catecholamine levels. A higher dose of endotoxin (0.2 mg/10 to 18 kg 
dog; 10% lethality) resulted in adrenal medullary secretion as well as 
stimulation of the adrenal cortex and a febrile response. Spinal 
transection at C-7 abolished the catecholamine release but left the 
adrenal cortical and febrile response intact. Thus, differential 
effects on the adrenal medulla and cortex were observed. Endotoxin 
elicited a sympathoadrenal response that was presumably dependent on 
descending spinal input. The results of this study were generally 
confirmed by a subsequent study by Hokfelt (70). Prager et al. (122) 
investigated the role of adrenal corticosteroids in the adrenal 
medullary response to endotoxin. Adrenal vein output of catecholamines 
and systemic arterial catecholamine concentrations were measured in dogs 
treated 
followed 
Endo toxin 
with either methylprednisolone sodium succinate (30 mg/kg) 
by endotoxin (0.5 mg/kg; 60% lethality) or endotoxin alone. 
elicited increases in arterial and adrenal venous 
7 
norepinephrine and epinephrine. Dogs pretreated with the corticosteroid 
demonstrated lower norepinephrine and epinephrine output from the 
adrenal gland than dogs not given corticosteroids; arterial 
norepinephrine was the same and arterial epinephrine was lower in dogs 
treated with the corticosteroid. Thus, the study demonstrated that the 
sympathetic nerves are activated during shock and that the adrenal 
component of the activation (epinephrine output) could be suppressed by 
corticosteroid administration - an intervention shown to be beneficial 
for survival in shock. 
Plasma catecholamine increases during endotoxic shock have also 
been shown to be blunted by other interventions. Feuerstein et al. (43) 
described increased plasma epinephrine and norepinephrine concentrations 
during two hours of endotoxemia in anesthetized cats. Prior injection 
with indomethacin, a prostaglandin synthesis inhibitor, attenuated the 
blood pressure decrease associated with endotoxin administration. The 
better hemodynamic status obtained with indomethacin also attenuated the 
norepinephrine and epinephrine increases. Devereux et al. (33) 
investigated the effect of heparin pretreatment on dogs in endotoxin 
shock. In control dogs injected with only endotoxin, plasma 
norepinephrine (superior vena caval cannula) but not epinephrine was 
increased. Heparin pretreatment effectively suppressed the 
norepinephrine increases. This report of no alterations in plasma 
epinephrine in endotoxic dogs with an intact splanchnic sympathetic 
supply is rare. Most studies have demonstrated that adrenal medullary 
secretion of epinephrine was extremely sensitive to the effects of 
8 
endotoxin. No speculation was made for the singular increase in plasma 
norepinephrine or the blunted norepinephrine response after heparin. 
Other studies using similar dog models have demonstrated 
increased plasma concentrations of norepinephrine and epinephrine 
(66,126,127). Rosenberg et al. (126,127) found that both norepinephrine 
and epinephrine increased markedly after endotoxin injection (dose was 
only reported as a "lethal dose") in morphine-sedated dogs. Plasma 
samples were taken from systemic venous blood. The increased 
epinephrine levels soon returned to control level, but norepinephrine 
remained slightly elevated throughout the ten hour procedure. When 
animals approached the throes of death and blood pressure fell 
precipitously, both plasma norepinephrine and epinephrine rose 
dramatically. The inverse correlation between blood pressure and plasma 
catecholamines is similar to the report of Nykiel and Glaviano (112) 
cited earlier. However, not all studies that measured hemodynamic 
parameters as well as circulating catecholamine levels showed the same 
relationship. Heiffer et al. (66) have documented increased circulating 
norepinephrine and epinephrine (blood samples taken from the marginal 
ear vein) during the post-hypotensive phase of endotoxic shock in the 
rabbit. It was noted that during the initial hypotensive phase, the 
plasma catecholamines were not changed from control. 
It is evident that many different results were obtained in the 
' 
outlined studies. Some of the catecholamine responses were dependent on 
blood pressure responses; some were not. Some models responded to 
9 
endotoxin with increases in epinephrine or norepinephrine or both 
catecholamines. The different findings can be attributed to different 
animal species, different doses of endotoxin, different sensitivities to 
endotoxin within a given animal species, and also different locations 
for blood withdrawal. With respect to species differences, Hall and 
Hodge (62) performed a comparative study on the effects of endotoxin on 
plasma catecholamine and angiotensin levels in dogs and cats. The 
vasoactive hormones were measured by bioassay (contractile response) 
using a continuous superfusion of rat colon and stomach strips for 
measurement of angiotensin and catecholamines (total norepinephrine and 
epinephrine), respectively. In light of other methodologies available 
at the time of this study (1971) to measure catecholamines, one might 
question the validity of the methods. However, the control and 
calibration experiments seemed adequate and the study deserves mention 
because of its comparative nature. In dogs, an immediate rise in 
angiotensin was observed, followed by a later variable rise in 
catecholamines. In cats, an early rise in plasma catecholamines 
occurred followed by a later rise in angiotensin. The results of this 
study demonstrated the variability of circulating neurohormonal levels 
in different species in response to endotoxicosis. The endotoxin dosage 
was 2 mg/kg infused over a 5 to 15 minute period. No indication was 
made concerning differential sensitivity of the different species to 
endotoxin except the note that all dogs and 11 of 12 cats survived the 
90 minutes of endotoxicosis observed. 
10 
Quantitatively, different results vere observed in the above 
reports. However, the important aspect of the studies is that, viewed 
as a whole, the vork constitutes a body of literature that indicates 
heightened sympathe~ic activity during endotoxic shock. Naturally this 
evidence is largely · indirect in nature since increased plasma 
catecholamines may be brought about by changes in not only release, but 
also reuptake, and degradation of the bioamines. However, no matter 
what the mechanism may be for increased circulating catecholamines, they 
vill activate postsynaptic receptors as well as, albeit less 
discriminately than, locally released catecholamines. The end result is 
a functional, if not actual, increase in sympathetic activity. However, 
the demonstration of increased plasma catecholamines does not answer the 
fundamental question: To what extent does activation of sympathetic 
nerves occur during endotoxin shock? 
2. DEPLETION OF TISSUE CATECHOLAMINES 
Terminals of neurons generally contain constant amounts of 
neurotransmitter greatly in excess of that necessary to respond to 
normal bursts of electrical activity. This is true in the case of 
sympathetic post-ganglionic neurons. Even under high stimulation rates 
the level of norepinephrine in sympathetic nerve endings (and hence in 
sympathetically-innervated tissues) normally remains constant. 
Depletion of the norepinephrine reserve can occur in a number of 
circumstances, as will be discussed in a later section, and generally 
indicates sympathetic dysfunction or intense hyperactivation of the 
nerves. 
11 
Unless synthesis of norepinephrine is blocked, norepinephrine 
depletion is usually interpreted as increased release or transfer of the 
neurotransmitter out of the neuron and into the interstitium. In 
endotoxin shock the occurrence of depressed tissue levels of 
catecholamines concomitant with increased circulating levels of the same 
has been interpreted as strong evidence for increased sympathetic drive. 
The first mention of depressed tissue catecholamine levels in 
endotoxin shock was by Dennis in 1939 (32). In a two page article, 
Dennis described the general reaction of laboratory animals (rabbits, 
guinea pigs, mice, and rats) to trichloroacetic acid extracts of 
defatted typhoid bacilli. Gross observations were reported during both 
the shock period and during necropsy. Within the discussion of the 
microscopic findings a single statement was made concerning 
catecholamine depletion in the adrenal glands: "The adrenals showed 
rapid loss of chromaffin material 3 hours after injection." The first 
report that focused on decreased tissue content of norepinephrine in 
endotoxic shock was by Heiffer, Mundy, and Mehlman in 1959 (25) and 1960 
(113). The brief summary described the effect of one or six hours of E. 
coli endotoxin administration (5 mg/kg) on the catecholamine content of 
the adrenal glands of rabbits. One hour after endotoxin the epinephrine 
content was significantly reduced; the norepinephrine content remained 
unchanged. After six hours, however, adrenal epinephrine content was 
reduced 68% and norepinephrine content was reduced 44% from 
time-matched, saline-injected, control rabbits. 
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Although the first reports were made years earlier, Fine and his 
associates were the first sroup or investigators to study this 
phenomenon 
subjected 
(164)· 
lethality. 
in detail (113,114,120,164,165). One study used dogs 
to either intravenous or cerebral intraventricular endotoxin 
Both routes of endotoxin administration resulted in 100% 
Catecholamines were analyzed by the trihydroxyindole 
fluorometric method. Four to seven hours after intravenous endotoxin 
injection, hearts, livers, and spleens were depleted of norepinephrine 
by 49%, 44%, and 22%, respectively. Intraventricular endotoxin (death 
occurred within ten to fourteen hours in all animals) caused decreased 
cardiac, hepatic, and splenic norepinephrine content of 31%, 17%, and 
22%, respectively. Additional work by the same researchers demonstrated 
that denervation of the abdominal viscera protected against endotoxic 
shock (114,165) as well as hemorrhagic shock (114,164,165). The celiac 
and superior mesenteric ganglia were surgically denervated in both dogs 
and rabbits (114). Animals were allowed three to eight weeks to recover 
before undergoing endotoxin administration. Both species were treated 
with endotoxin intravenously; endotoxin injection into cerebral 
ventricles was performed in another group of dogs, and additional 
rabbits were injected subdurally with endotoxin. Denervation of the 
abdominal viscera significantly increased survival rate (surviving 
animals were sacrificed four to twelve days after the shock procedure) 
in all 
endotoxin. 
rabbits. 
models except those rabbits injected intravenously with 
The protection in dogs was far more dramatic than in 
Hemodynamic data were presented that demonstrated better 
perfusion to the splanchnic area in denervated animals. The- authors 
attributed the 
reticuloendothelial 
protection 
function. 
to the sparing of liver 
13 
and 
Their conclusion was that chronic 
surgical denervation of the splanchnic nerves decreased both the release 
of norepinephrine and the subsequent vasoconstriction and flow 
deprivation to the liver and intestine which resulted in better function 
of these organs. 
Fine and associates also demonstrated that acute denervation of 
the abdominal viscera protected against the norepinephrine depletion 
during endotoxic shock (165). One half of the nervous supply to spleens 
of dogs was interrupted acutely prior to endotoxin administration. 
During shock, the denervated hemi-spleens were not depleted of 
norepinephrine, continued 
norepinephrine, and showed 
innervated half-spleens. 
conclusion drawn by the 
to contract in response to exogenous 
no histopathologic changes compared to the 
Throughout these studies, the fundamental 
investigators was that the depletion of 
norepinephrine was caused by massive release of the catecholamine (in a 
rate exceeding the ability of the neuron to synthesize it). The 
importance of the depletion was that the action of the liberated 
norepinephrine damaged the splanchnic organs and the myocardium and was 
thus one of the major mechanisms responsible for the pathogenesis of 
shock. 
Pohorecky, Wurtman, Taam, and Fine demonstrated norepinephrine 
depletion in the endotoxic rat for the first time in 1972 (120). Five 
hours after various doses of endotoxin (1 to 5 mg endotoxin per 200-250 
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gm rat, intraperitoneally) norepinephrine content was measured in heart, 
spleen, and adrenal glands. A positive dose-response relationship was 
found i.e. the greater the endotoxin challenge, the greater the 
norepinephrine depletion. Additional experiments showed that for a 
given dose of endotoxin (4 mg per rat) the norepinephrine depletion in 
spleen and adrenals was proportional to the length of time of 
endotoxicosis. 
Recently, Bolton and Atuk, in a study of the effects of the 
sympathetic nervous system on endotoxin-induced lethality in rabbits, 
demonstrated norepinephrine depletion in hearts, kidneys, and lungs (9). 
Endotoxin was administered to rabbits (1.5-2.0 kg) at two times: an 
original slow intravenous injection of 0.4 mg followed 18 hr later by a 
0.2 mg intravenous injection. Approximately 30% of the animals died 
within 18 hours of the initial injection; 30% died within 24 hours of 
the second endotoxin injection. The remaining rabbits were killed 24 
hours after the second injection. When animals dying at all times were 
analyzed together, norepinephrine depletion was evident in heart, 
kidney, and lung. The long term effect of endotoxin on norepinephrine 
depletion in surviving animals could potentially have been studied if 
the authors had grouped the animals according to time of death. 
Thus, norepinephrine depletion has been demonstrated in a 
variety of endotoxic animal models. The work of Fine and associates has 
shown that the depletion was avoided if the nervous supply to the organ 
in question was sectioned or blocked with an anesthetic. These results 
suggested that the norepinephrine depletion 
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was dependent on 
nerve-stimulated release and that endotoxin did not act directly on the 
nerve terminals to elicit transmitter release. Thus, the mechanism of 
depletion must be subsequent to nerve stimulation. However, the 
magnitude of sympathetic activation in shock is still in question. Some 
of the above and other studies investigated the mechanism of 
norepinephrine depletion and will be reviewed in a latter section. 
3. RADIOISOTOPIC STUDIES 
Radioisotopic labeling of neurotransmitters and their 
incorporation into existing transmitter pools enable design of 
experiments that reveal much more information than measurement of 
endogenous transmitter levels in tissue or plasma. Several studies have 
been performed in endotoxic models and have suggested that sympathetic 
activity was increased. However, while a potentially powerful tool was 
utilized, the experimental design limited the interpretation of the 
results. 
The study of Pohorecky .!_!al. (120) that described a time- and 
dose- response relationship between endotoxin and norepinephrine 
depletion also investigated catecholamine metabolism using radiolabeled 
norepinephrine. One hour before endotoxin injection (intraperitoneally) 
rats were injected intravenously with 3H-norepinephrine to allow the 
labeled transmitter to be taken up by sympathetic nerve endings and 
equilibrate with the endogenous pool. Different doses of endotoxin were 
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injected and five hours later hearts, spleens, and adrenal glands were 
analyzed for 3H-norepinephrine content. 'l'he experiments demonstrated 
that endotoxin (in a dose-dependent manner) reduced the amount of 
'H-norepinephrine that remained in the tissues in question. Also, 
similar experiments 
endotoxin (4 mg/rat) 
endotoxin) on the 
were performed to test the effect of one dose of 
at hourly intervals (up to five hours after 
'H-norepinephrine content of tissues. A 
time-dependent decrease in labeled norepinephrine was observed. The 
results were interpreted as indicative of increased norepinephrine 
turnover and hence increased sympathetic activity during endotoxicosis. 
Kinetic analysis of 3H-norepinephrine decay in tissues to measure 
norepinephrine turnovers requires a different experimental design than 
used in the study. In the dose-dependent experiments endogenous 
norepinephrine as well as labeled norepinephrine decreased. It is 
difficult to interpret the results of various endotoxin dosages at one 
time after endotoxin injection. One might interpret the results as a 
dose-dependent effect of endotoxin to inhibit synthesis and increase 
degradation with no effect on norepinephrine release. Inhibition of 
norepinephrine synthesis would result in parallel decreases in 
endogenous and labeled norepinephrine; increased degradation due to 
endotoxin could also, in a dose-dependent manner, cause a parallel 
decrease in both labeled and unlabeled norepinephrine in a tissue. In 
the other set of experiments the time-dependent decrease in both 
endogenous and labeled norepinephrine (using one dose of endotoxin) 
demonstrates very little. No time-matched control series were performed 
to determine a normal decay of labeled norepinephrine in the tissues. 
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Additionally, because the endogenous content of norepinephrine also 
decreased over the five hours of the experiment, one might make the 
interpretation that endotoxin simply inhibited norepinephrine synthesis. 
Thus, both endogenous and labeled norepinephrine fell in parallel and no 
changes in specific activity were noted. 
A study by Rao et al. (123) investigated norepinephrine 
metabolism in the endotoxic dog using 3H-norepinephrine. Endotoxin (2 
mg/kg) was administered to dogs 30 minutes after injection of 
3H-norepinephrine. Femoral artery blood samples were drawn 3, 5, and 30 
minutes after endotoxin administration. Plasma 3H-norepinephrine 
concentrations 
respectively. 
were 63%, 90%, and 75% of pre-injected controls, 
Analysis of 3H-normetanephrine at the same times 
disclosed labeled metabolite increases of 48%, 92%, and 102% at the 
indicated times. Labeled norepinephrine and normetanephrine were also 
measured in individual organs. 3H-norepinephrine in atria, left 
ventricles, and kidneys was unchanged 30 minutes after endotoxin 
injection; the levels in spleens and adrenal glands were increased. In 
all organs, labeled normetanephrine increased. Vague conclusions and 
interpretations were made: The authors suggested that increased release 
and metabolism of catecholamines had occurred. 
information was gained by this study. 
Little conclusive 
Cavanagh!_! al. (.16) measured numerous hemodynamic, hematologic, 
and neurohumoral parameters in a primate model of endotoxicosis. Plasma 
norepinephrine was assessed by quantitating the am~unt of 
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'H-norepinephrine present in blood after an endotoxic challenge (7 
mg/kg). Prior to endotoxin, the labeled amine was injected into the 
baboons, allowed to be taken up in sympathetic nerve endings, and 
equilibrate with the endogenous pool. The radioactivity in the plasma 
associated with norepinephrine increased 50% within 3 minutes of 
endotoxin injection. The 3H-norepinephrine level in plasma then 
decreased with time and was no different than control by two hours after 
endotoxin. This study did not quantitate the actual norepinephrine 
concentration in plasma, and also failed to quantitate the amount of 3H 
that was associated with the products of norepinephrine metabolism. The 
level of 3H-norepinephrine in the plasma is dependent on release and 
degradation of 
labeled amine 
the bioamine; it is also dependent on the catabolism of 
within the nerve terminal prior to its release. 
Interpretation of the data is difficult. The conclusions of increased 
sympathetic activity may be entirely correct, but the experimental 
design does not allow more than a vague, qualitative conclusion to be 
made. 
Conclusions from the above studies have indicated increased 
sympathetic drive during shock. Indeed, the study of Pohorecky (120) 
has been widely quoted in the shock literature as demonstrative of 
increased norepinephrine turnovers during endotoxic shock in the rat. 
However, closer inspection of the design of the studies raises questions 
regarding the strength if not the validity of the conclusions. 
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4. ELECTROPHYSIOLOGICAL STUDIES 
The most direct method to assess sympathetic nerve function is 
to measure it directly by electrophysiologic methods. Several studies 
have employed this approach to assess sympathetic function in the 
endotoxic cat and dog, but the results of the different studies are 
conflicting. 
Halinen (61), studied early effects of endotoxin (up to 15 
minutes after administration) on cardiac efferent nerve activity in 
chloralose-anesthetized acid-base-controlled dogs. He reported increased 
cardiac postganglionic sympathetic activity for the duration of the 
experiment compared to control. At the time, aortic pressure had 
dropped markedly. Concomitantly, aortic arch baroreceptor activity was 
decreased. Unexpectedly, cervical vagal efferent activity increased 
after endotoxin administration. It was concluded that sympathetic 
pathways were functional early after endotoxin administration and that 
the increased discharges were primarily reflex in nature to maintain 
blood pressure. Endotoxin was speculated to modify baroreceptors, 
mechanoreceptors, or chemoreceptors. It was proposed that vagal tone 
increased after endotoxin because of chemoreceptor activation. A group 
of dogs was additionally given a small dose of pentobarbital to examine 
the possible modifying effects of the anesthetic on the results. The 
essential results were that the pentobarbital accentuated both the 
increased cardiac sympathetic efferent and cervical vagal efferent 
activity. 
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The modification vas performed because many previous 
hemodynamic studies had used pentobarbital as an anesthetic. 
In contrast to the work of Halinen (61), two reports in abstract 
form by Koyama et al. (86) and Santiesteben et al. (130) in the same 
laboratories, indicated that preganglionic splanchnic nerve activity was 
decreased after endotoxin injection in the chloralose-anesthetized cat 
even though blood pressure was significantly reduced. At no time during 
the 60 minute experiment vas nerve activity increased over normal. 
Preganglionic splanchnic nerve activity was increased, however, in 
response to hypotension induced by hemorrhage in the same animal model 
(86). The authors concluded that arterial baroreceptors did not buffer 
endotoxic hypotension as effectively as hypovolemic hypotension. 
Autonomic afferent function has also been assessed before and 
after administration of endotoxin (149). Baroreceptor discharge 
frequency was measured as a function of intrasinus pressure using an 
isolated sinus model in the dog. The relationship of discharge 
frequency versus pressure was shifted to the left indicating that the 
baroreceptors were firing 
stimulus. The conclusion 
maintain blood pressure at 
at 
was 
a 
a higher rate for a given pressure 
that the baroreceptors were reset to 
hypotensive level. It would then be 
consistent with these results that baroreceptor-stimulated sympathetic 
efferent activity was depressed in endotoxicosis. 
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Nerve recording would be expected to yield the most direct and 
clearest results. However, investigations during endotoxin shock have 
not been conclusive. Differences in the studies may be attributed to 
differences in species or anesthesia. Additionally, the experiments of 
Koyama and Santiesteban measured sympathetic preganglionic activity from 
the splanchnic region. 
cardiac nerve activity. 
Halinen measured sympathetic postganglionic 
It should also be noted that in all cases an 
anesthetized preparation was used which can easily modify autonomic 
nerve activity. In summary, no clear conclusions can be drawn from the 
existing literature on direct sympathetic nerve recording during 
endotoxin shock. 
B. Evidence Supporting the "Pathogenetic" Properties of the Sympathetic 
Ne~ System in Endotoxin Shock 
The role of sympathetic nervous system activation in the 
pathogenesis of endotoxic shock has been extensively investigated and 
tested. Probably the first proposal for an autonomic mechanism in the 
action of endotoxin was by Reilly and associates, a group of French 
investigators, in 1935 (125). According to Thomas in a 1954 review on 
the physiological disturbances produced by endotoxins (147), the "Reilly 
phenomenon" received relatively little attention in American scientific 
literature. The theory held that there was a "selective affinity of 
endotoxin for sympathetic nervous system tissues." Evidence that 
supported this concept included the effect of small amounts of endotoxin 
injected in the vicinity of the splanchnic nerve that caused hemorrhage 
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and necrosis in the splanchnic region, shock, and death. Even larger 
amounts of endotoxin injected intramyocardially or by other routes had 
no effect. 
The production of synthetic analogues of norepinephrine and 
epinephrine in the 1950's spurred much research in this area. Through 
the 1950's, therapeutic augmentation of sympathetic activity during all 
types of circulatory shock was an accepted clinical procedure (97). 
However, not all evidence supported this concept. Although adrenergic 
agonists were capable of maintaining blood pressure during the early 
phases of shock (154), overall survival was not improved (96,136). 
Zweifach et al. (167) demonstrated that endotoxin sensitized blood 
vessels to the effects of catecholamines. This finding was not 
confirmed in a similar preparation, however (104). Injection of 
epinephrine intradermally was shown to cause hemorrhagic necrosis when 
either preceded or followed by endotoxin injection (148). Indeed, 
infusion of catecholamines alone were shown to cause a shock-like state 
(49,103,158,161). Thus, by the 1960's, the foundations for a new 
working hypothesis regarding the protective effects of sympathetic 
blockade during shock were formed. Interestingly, one of the first 
reports of adrenergic blockade during endotoxicosis was as early as 1950 
by Boquet and Izard (10). Dibenzyline, an alpha adrenergic antagonist, 
reversed the vascular constriction of rabbit ears to typhoid endotoxin. 
However, the administration of dibenzyline after endotoxin did not 
affect the lethality of the syndrome. The authors concluded that 
endotoxin liberated epinephrine or epinephrine-like substances which 
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caused intense vasoconstriction that could be blocked by sympathoadrenal 
antagonists. Major contributions by Nickerson and Lillehei documented 
the beneficial effects of blunting the actions of the sympathetic 
nervous system. It is at this juncture that pertinent literature of 
this area will be reviewed. 
Gourzis, Hollenberg, and Nickerson (58) confirmed in rabbits the 
findings of Zweifach et al. (167) that endotoxin increased the pressor 
response to epinephrine and norepinephrine. Additional studies 
demonstrated that isotonic contractions of aortic strips incubated in 
vitro with endotoxin and whole blood were increased in response to 
endotoxin. No such increase was noted if blood or its constituents were 
replaced with a buffer solution. The Nickerson study also tested the 
lethality of endotoxin in rabbits and mice with and without two agents 
that blunt adrenergic responses. Results indicated that pretreatment 
with reserpine (causing depletion of endogenous norepinephrine stores) 
or phenoxybenzamine (blocking alpha adrenergic receptors) significantly 
decreased endotoxic lethality in both species. Pretreatment of mice 
with phenoxybenzamine doubled the dose of endotoxin necessary to induce 
a 50% lethality. 
In a landmark publication Lillehei and MacLean (96) demonstrated 
the benefit of adrenergic blocking agents in canine endotoxin shock. 
Adrenergic · agonists were shown to sensitize dogs to lethality in their 
endotoxic model (84% lethality with endotoxin alone; 100% lethality with 
norepinephrine or metaraminol given concomitantly with endotoxin). 
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Metaraminol also potentiated the effect of a sublethal dose of endotoxin 
(measured as an increase in lethality). Pretreatment with either 
chlorpromazine or phenoxybenzamine was used to block the vasoconstrictor 
effects 
dogs of 
of catecholamines released during endotoxicosis. All of the 
both these groups survived (Seventy-two hours after endotoxin 
dogs were considered permanent survivors.). On autopsy, animals treated 
with adrenergic antagonists showed normal bowel morphology and only 
moderate liver congestion and renal tubular damage compared to the 
endotoxic controls. Subsequently, a hemodynamic mechanism to explain 
the beneficial effects of adrenergic blockade in a similar model was 
investigated (73). Results demonstrated that alpha adrenergic blockade 
augmented venous return in dogs treated with endotoxin by decreasing the 
pooling of blood in the liver and other areas. The initial blood 
pressure drop after endotoxin was eliminated by phenoxybenzamine, but 
pressures were comparable in both groups by thirty minutes after 
endotoxin administration. 
blood pH, or hematocrit. 
Alpha blockade had no effect on heart rate, 
More recently, the combination of a prostaglandin synthesis 
inhibitor, indomethacin, and phenoxybenzamine has been shown to increase 
survival of endotoxic rats (57). This effect was attributed to the 
superior hemodynamic status of the treated rats. The increased survival 
of endotoxic rats pretreated with alpha adrenergic blocking agents has 
also been shown to be associated with improved metabolic homeostasis. 
Filkins (46) demonstrated that alpha adrenergic blockade prevented the 
depression of hepatic gluconeogenesis associated with endotoxic shock 
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and protected against endotoxic hypoglycemia. However, the same study 
reported that beta adrenergic blockade sensitized rats to endotoxic 
lethality, depression of hepatic gluconeogenesis, and endotoxic 
hypoglycemia. A subsequent study by Kaelin and Rink (82) measured 
hepatic oxygen supply in the same model. They ascribed the improved 
metabolic status of the alpha blocked endotoxic rat to the ability of 
phentolamine to increase hepatic oxygen supply through its vasodilating 
properties. 
Attempts have been made to blunt adrenergic vasoconstriction in 
endotoxic shock by making animals tolerant to the effects of 
catecholamines (34,71). Tolerance can be accomplished by injecting 
animals regularly with sublethal doses of epinephrine; subsequent 
injection with normally lethal doses of epinephrine does not result in 
death (37,152). In their study, Dietzman et al. (99) demonstrated that 
while 10% of control dogs survived an endotoxin challenge, 100% of 
epinephrine tolerant dogs survived the same dose of endotoxin. Data 
were presented to demonstrate the improved hemodynamic status of 
epinephrine 
adrenergic 
tolerant dogs. 
responsiveness in 
Hruza et al. (71) produced blunted 
rats by injecting epinephrine or 
norepinephrine suspended in oil 30 minutes prior to endotoxin injection. 
The procedure significantly protected rats against endotoxic lethality. 
If rats were previously eviscerated, the pretreatment did not affect 
lethality, implicating visceral vasoconstriction in endotoxic shock. It 
was concluded that the slowly diffusing catecholamines induced a 
decreased responsiveness to adrenergic stimuli or "autoregulatory 
escape " before 
protection. The 
stressed by Fine 
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endotoxin was administered and thereby afforded 
importance of splanchnic vasoconstriction has been 
previously (47), and the beneficial effects of 
splanchnic denervation have already been discussed in a previous section 
{114,164,165). 
Finally, sympathectomy has been shown to have variable effects 
prior to endotoxin shock {2,9,58,99,150). Chemical sympathectomy in 
newborn rats (within the first few hours of birth) by either 
guanethidine, bretylium tosylate, or 6-hydroxydopamine did not affect 
survival after endotoxin injection compared to non-sympathectomized 
control rats (2). The lack of protection in newborn rats may have 
occurred because the sympathetic nerves were not fully developed at that 
time. Therefore, even the non-sympathectomized control rats may have 
had negligible 
pretreatment did 
adrenergic responses to endotoxin. 6-Hydroxydopamine 
afford protection (9) against endotoxin lethality in 
adult rabbits (64% control rabbits died; 25% of the sympathectomized 
rabbits died). Sympathectomy with reserpine in rabbits and mice also 
decreased lethality associated with endotoxin administration (58). 
Spinal block by epidural anesthesia sensitized dogs to hemodynamic 
demise and lethality in endotoxin shock (99). Because blood pressure 
fell precipitously after endotoxin in the spinal group, the authors 
concluded that total lack of sympathetic vasoconstriction was 
detrimental in endotoxicosis. However, sympathectomy by complete spinal 
blockade lacks a great deal of specificity and compromises hemodynamic 
st~tus much more than sympathetic chain extirpation. - Chemical 
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sympathectomy in dogs with 6-hydroxydopamine in the presence of adrenal 
demedullation also did not affect cardiopulmonary responses compared to 
dogs treated with endotoxin alone (150). However, 6-hydroxydopamine 
8 ympathectomy was not investigated in the presence of intact adrenals. 
In addition to the literature cited showing no beneficial 
effects of sympathectomy during endotoxic shock, many reports describe 
the lack of protective affects afforded by adrenergic blockade in shock 
(63,69,87,102). Hinshaw and associates are of the strong influence that 
catecholamines and sympathetic activation are not a primary cause of 
pathologic hemodynamic changes during endotoxicosis, but that they may 
be secondary contributors to the splanchnic pooling and pre- and 
post-capillary resistance changes (69,87,102). In this regard, 
splanchnic denervation and adrenalectomy (69), alpha adrenergic blockade 
(102), and extirpation of the sympathetic chain and vagi (87) in dogs 
subsequently treated with endotoxin afforded no protection. Combined 
alpha and beta adrenergic blockade in the dog also did not afford any 
protective effects on hemodynamics during endotoxemia (63). 
However, in the majority of cases, blunting of the sympathetic 
nervous system has been shown to protect against the pathogenesis of 
endotoxic shock. Evidence indicates that alpha adrenergic activation in 
shock compromises both hemodynamic and metabolic homeostasis. 
Conversely, beta adrenergic stimulation has not specifically been shown 
to be detrimental and through its vasodilating properties may actually 
be hypothesized to protect against the pathogenesis of endotoxin shock. 
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c. Tissue Norepinephrine Levels Physiological and Pathological 
processes 
Depletion of norepinephrine from tissues has been reported in a 
variety of circumstances. Pharmacologic manipulation of catecholamine 
metabolic processes that inhibit synthesis (140) or vesicularization 
(106) of norepinephrine depletes the transmitter from nerve terminals. 
Also, chemical sympathectomy with 6-hydroxydopamine (107,121) or 
guanethidine (44) displaces norepinephrine from nerve terminals thereby 
depleting them of transmitter. Pathophysiological situations have also 
been shown to deplete norepinephrine. Clinically, norepinephrine is 
reduced in cardiac muscle from patients in congestive heart failure 
(18,21). In experimental models of cardiovascular disease, 
norepinephrine depletion has been documented in: 1) hearts of dogs (20) 
and rodents (131) in surgically induced chronic heart failure, 2) hearts 
and spleens of hamsters with genetic cardiomyopathies (138,139), and 3) 
canine hearts after left anterior descending artery occlusion (166). 
Acute induction into hypothermia (81) or chronic cold exposure in 
rodents (80) lowers norepinephrine levels in peripheral tissues. 
Immobilization stress also activates the sympathetic nervous system and 
causes cardiac norepinephrine depletion (139). Evidence has already 
been presented that documents norepinephrine depletion from both central 
nervous and peripheral tissues during endotoxin shock. In hemorrhagic 
shock the same phenomenon has also been reported (23,30,40,52,55,68). 
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Basic knowledge of the physiologic processes that regulate 
norepinephrine levels in tisses is a prerequisite for: 1) effective 
evaluation of literature addressing the pathologic changes underlying 
norepinephrine depletion during endotoxicosis and 2) design of 
experiments that further investigate the phenomenon. A brief review of 
the factors that determine norepinephrine content in peripheral tissues 
under normal conditions will first be presented. A survey of 
circulatory shock literature reveals that norepinephrine depletion in 
tissues is not confined to endotoxic shock. As mentioned, hemorrhagic 
models of shock have been shown to induce similar situations of 
norepinephrine depletion. Indeed, some reports have simultaneously 
investigated the depletion in both endotoxic and hemorrhagic models. 
Because knowledge of norepinephrine depletion during hemorrhage can shed 
light on possible mechanisms of endotoxin-induced norepinephrine 
depletion, and because many of the vascular lesions are similar in both 
of these types of shock, the literature addressing norepinephrine 
depletion during hemorrhagic shock will also be reviewed. No literature 
review of norepinephrine depletion in other types of circulatory shock 
will appear 
investigated. 
mechanisms of 
reviewed. 
because the phenomenon has not been extensively 
Finally, the existing literature that addresses possible 
catecholamine depletion in endotoxin shock will be 
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1. MAINTENANCE OF TISSUE NOREPINEPHRINE LEVELS UNDER NORMAL CONDITIONS 
The adrenergic neuron stores norepinephrine within vesicles that 
exhibit characteristic dense cores when examined under the electron 
microscope after 
norepinephrine 
biosynthesis of 
in 
appropriate fixation (60,101). Genesis of a pool of 
nerve terminals is ultimately dependent upon 
the neurotransmitter. The normal precursor of 
norepinephrine is tyrosine, usually derived from dietary sources. Three 
enzymatic reactions within the neuron convert tyrosine to the final 
product, norepinephrine. The first reaction is the hydroxylation of 
tyrosine to DOPA (L-3,4-dihydroxyphenylalanine) by tyrosine hydroxylase, 
which is also the rate limiting step in the biosynthetic pathway (95). 
The enzyme requires oxygen and a pteridine cofactor (11 ,74,108). The 
second enzyme in norepinephrine biosynthesis, aromatic amino acid 
decarboxylase, is a relatively nonspecific enzyme that catalyzes the 
decarboxylation of DOPA to dopamine (98). The final reaction, 
conversion of dopamine to norepinephrine, is catalyzed by dopamine beta 
hydroxylase, and takes place within or on the storage granules 
(8,84,93). The rate of norepinephrine synthesis is closely related to 
the activity of the sympathetic neuron. Thus, both in vivo (31 ,56) and 
in vitro (128,155) sympathetic nerve stimulation are accompanied by 
increased norepinephrine synthesis from tyrosine, via increased activity 
of tyrosine hydroxylase. Early studies concluded that this occurred 
because tyrosine hydroxylase activity was modulated by end-product 
(norepinephrine) feedback inhibition (74,141 ,151). Recent evidence 
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suggests that tyrosine hydroxylase exists in high and low activity 
forms, with high and low affinity for the pterin cofactor, respectively. 
Stimulation of adrenergic nerves results in conversion of the enzyme to 
the high affinity form (155,156). It has been postulated that the 
conversion to the high affinity form by nerve stimulation may be 
dependent 
tyrosine 
Regardless 
on a cyclic AMP-dependent protein phosphorylation of either 
hydroxylase or one of its activators or inhibitors (156). 
of the mechanism, increased norepinephrine synthesis in 
response to nerve stimulation is an important mechanism to replenish the 
stores of norepinephrine released, and maintain constant levels of 
norepinephrine in the nerve terminal (6). 
Catabolism of norepinephrine is initiated through two major 
metabolic pathways: oxidative deamination by monoamine oxidase (MAO) and 
methylation by catechol .Q-methyltransferase (COMT) (134). Monoamine 
oxidase is primarily localized in mitochondria (28,132), is present in 
adrenergic neurons (137), and is responsible for catabolism of 
intraneuronal, 
the monoamine 
norepinephrine 
cytoplasmic norepinephrine. Treatment of animals with 
oxidase inhibitor, pargyline, leads to increased 
levels in adrenergically innervated tissues (141). This 
evidence implicates intraneuronal degradation in modulation of tissue 
norepinephrine levels. Catechol .Q-methyltransferase is probably not 
important for catabolism of intraneuronal norepinephrine. It is more 
important for catabolism of circulating norepinephrine, and is found in 
highest concentrations in the liver and kidney (4). 
An active 
norepinephrine from 
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neuronal uptake process (Uptake 1) recovers 
the interstitium against a concentration gradient 
(76). This process is carrier-mediated, requires energy, is 
temperature-dependent, and can be inhibited by prolonged exposure to 
8 noxia or metabolic poisons such as dinitrophenol or cyanide (76). The 
presence of extracellular sodium ions is necessary (75,129) as are low 
concentrations of potassium ions (51,116). Neuronal reuptake can be 
selectively blocked by a variety of agents, cocaine and 
desmethylimipramine being two of the most potent antagonists (77). 
Because Uptake is rapid and efficient (75% to 80% of norepinephrine 
released from nerve terminals may be recovered) it has been implicated 
as the process that terminates the effects of sympathetic nerve 
stimulation by removing the neurotransmitter from the synaptic area 
(76,77). Another role of Uptake 1 is to conserve norepinephrine within 
the nerve terminal and contribute to maintenance of constant levels, 
especially during conditions of high sympathetic nerve activity. Thus, 
when rats were pretreated with specific Uptake 1 blockers and exposed to 
cold (to increase sympathetic activity), cardiac catecholamine levels 
dropped markedly, but were unaltered if Uptake 1 was not inhibited (6). 
Although norepinephrine is synthesized within the granule, 
norepinephrine is also present in the cytoplasm due to its uptake from 
the extracellular space. The storage of norepinephrine within vesicles 
(repackaging) is dependent on an active uptake process from the 
cytoplasm that concentrates norepinephrine against a concentration 
gradient (78). The process is temperature dependent, requires ATP and 
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Mg++, and can be selectively inhibited by reserpine (38,106,143). 
Inhibition of vesicular reuptake results in the degradation of 
norepinephrine recovered by Uptake 1 in the cytoplasm by the action of 
monoamine oxidase and lowers norepinephrine content in the terminal 
(106). Thus, constant norepinephrine levels are dependent on vesicular 
reuptake as well as Uptake 1. 
The amount of norepinephrine released per nerve stimulus can be 
modulated by numerous factors (92,157). In this regard, many 
investigations have been directed toward the role of presynaptic 
receptors. Stimulation of presynaptic alpha adrenergic receptors 
decreases the amount of norepinephrine overflow measured from various 
tissues in response to nerve stimulation. Similarly, adenosine, 
dopamine, and muscarine receptors inhibit nerve-stimulated release of 
norepinephrine (157). In contrast, stimulation of presynaptic beta 
adrenergic receptors augments nerve stimulated norepinephrine release 
(1). Prostaglandins have been reported to have both stimulatory and 
inhibitory effects related to their series (13). Although manipulation 
of these processes have not been demonstrated to affect norepinephrine 
levels in tissues, modulation of norepinephrine release by this 
mechanism may have effects on norepinephrine pool size under conditions 
of high sympathetic activity. 
Figure summarizes the various processes that determine the 
norepinephrine content in nerve terminals. Two major processes augment 
the tissue content of norepinephrine. Biosynthesis of norepinephrine 
Figure 1. 
Diagram illustrates the processes that determine the 
norepinephrine content in peripheral tissues. Arrows and + or -
indicate the relative contribution of the process on the norepinephrine 
content (+: increase or-: decrease). See text for details. 
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from its precursor, tyrosine, is the initial process in creating a pool 
of norepinephrine in the nerve terminal and contributes to maintaining 
the pool by increases in tyrosine bydroxylase activity and hence 
synthesis in the face of increased sympathetic drive. Uptake 1 is 
responsible for conservation of released norepinephrine. The reuptake 
process is important not only in augmenting the norepinephrine pool, but 
also is the primary mechanism for terminating the action of 
norepinephrine at the neuroeffector site. Two major processes decrease 
the content of norepinephrine in nerve endings: intraneuronal 
degradation by the action of monoamine oxidase, and release of 
norepinephrine from nerve t~rminals by postganglionic sympathetic nerve 
activity. Finally, modulation of nerve-stimulated release of 
norepinephrine can either increase or decrease the amount of 
neurotransmitter released per nerve stimulus. Normally, a steady-state 
exists between these five processes to maintain a constant pool of 
norepinephrine in the tissue. 
2. NOREPINEPHRINE DEPLETION DURING HEMORRHAGIC SHOCK 
a.) Demonstration of the Phenomenon 
The earliest quantitation of norepinephrine depletion from 
peripheral tissues during hemorrhagic shock was in 1961 by Glaviano and 
Coleman (52). Twelve unanesthetized rabbits were subjected to 
hemorrhagic 
Compared 
hypotension (arterial pressure of 50 mmHg) for three hours. 
to the twelve normotensive animals, left ventricular 
norepinephrine content of hypotensive animals was reduced 85% from a 
control 
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of 1.05 + 0.13 »g/gm to 0.16 + 0.05 vg/gm (p<0.001). 
conversely, left ventricular epinephrine in the same animals was 
increased 72% in the hypotensive group from a control of 0.14 ~ 0.06 
vg/gm to 0.24 ~ 0.06 ~g/gm (p<0.01). Injections of graded doses (25 to 
500 ug/kg) of norepinephrine in hypotensive rabbits caused elevation of 
myocardial norepinephrine in a dose-dependent fashion. The increased 
myocardial epinephrine content was interpreted as uptake of circulating 
epinephrine rather than de novo synthesis of the bioamine in the 
myocardium. This is highly likely because: 1) circulating epinephrine 
is increased during hemorrhagic shock and 2) the enzyme responsible for 
the conversion of norepinephrine to epinephrine, 
phenylethanolamine-N-methyltransferase (PNMT), is present primarily in 
the adrenal medulla (8). In light of catecholamine-induced augmentation 
of myocardial contraction and metabolism, the authors speculated that 
the genesis of myocardial failure in hemorrhagic shock may be due to 
norepinephrine depletion and concomitant lack of norepinephrine release. 
I 
In the same model, Coleman and Glaviano (23) subsequently demonstrated 
that three hours of hemorrhagic hypotension caused norepinephrine 
depletion from brain, liver, and the previously described depletion from 
the heart and spleen, but not from skeletal muscle. Epinephrine content 
was significantly increased in heart, spleen, brain, and liver, and not 
changed in skeletal muscle. 
Subsequently, norepinephrine depletion was reported to occur in 
other hemorrhagic models. Hift and Campos demonstrated that 
irreversible hemorrhagic shock depleted cardiac norepinephrine in a 
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canine model (68). Fasted, pentobarbital-anesthetized mongrel dogs were 
subjected to a modified Wiggers hemorrhagic procedure (67): Dogs were 
bled rapidly to 40 mmHg arterial pressure, were maintained at this level 
by withdrawing or infusing small amounts of blood on demand until the 
"agonal state", and were sacrificed at that time by excision of the 
heart. Paired time-matched control dogs were subjected to similar 
pentobarbital anesthesia and blood pressure measurement. Ventricles and 
atria of shocked dogs contained on the average 50% less norepinephrine 
than their time-matched controls. In a regional study of cardiac 
norepinephrine depletion, Gomez-Povina and Canepa (55) reported that the 
norepinephrine depletion in pentobarbital-anesthetized hemorrhagic dogs 
was more marked in the left ventricle than in the right ventricle. Dogs 
were bled to 30 mmHg arterial pressure and maintained for 135 or 180 
minutes and then either sacrificed or reinfused with their own blood and 
maintained for another 300 minutes. The more severe depletion of left 
ventricular norepinephrine was evident in both the 135 and 180 minute 
hemorrhage group. The depletion was partially reversed by retransfusion 
of blood into the dogs. As in the study of Coleman and Glaviano (52), 
myocardial epinephrine was increased during the hemorrhagic insult. 
Farnebo and Hamberger (40) utilized fluorescent microscopy and 
biochemical techniques to demonstrate depletion of adrenergic nerves in 
pentobarbital-anesthetized hemorrhagic rats. Rats were bled through 
femoral arterial catheters to a blood pressure of 35 mmHg, maintained 
for four hours, and sacrificed. Histochemical determination of 
norepinephrine demonstrated a decrease of the bioamine in the iris, 
and blood vessel 
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innervation of submandibular and su~lingual spleen, 
gland. 
sublingual 
The heart and parenchymal innervation of the submandibular and 
gland were unaffected by hemorrhage. Biochemical 
determination of norepinephrine demonstrated decreased norepinephrine in 
brain tissue, marginally decreased norepinephrine in salivary gland, and 
increased norepinephrine in cardiac tissue. The discrepancy betwe~n 
histofluorescent and biochemical determinations of norepinephrine in the 
heart were attributed to the interference of quenching phenomenon in the 
histofluorescent technique. The conclusions were that discrete 
activation of sympathetic nerves occurred during hemorrhagic shock in 
the rat, resulting in depletion of norepinephrine from discrete 
sympathetically innervated organs as well as discrete areas within 
organs. Recent work by the same group (41) described a more pronounced 
sympathetic 
anesthetized 
by higher 
hemorrhagic 
drive in the unanesthetized hemorrhagic rat compared to the 
counterpart. More active sympathetic drive was evidenced 
plasma catecholamine levels. In the unanesthetized 
rat skeletal muscle and adrenal tissue was depleted of 
catecholamines and cardiac norepinephrine stores were decreased 
non-significantly. 
Neurochemical techniques have localized the norepinephrine 
depletion to the sympathetic nerve terminal (30,68). In the 
aforementioned article by Hift and Campos (68) tissues were centrifuged 
at various speeds to localize the norepinephrine content to specific 
subcellular fractions. The depletion of norepinephrine was greatest in 
the particulate fraction that sedimented on high speed centrifugation 
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(63% in atria; 68% in ventricles) and less in the soluble and coarse 
fractions. Presumably the particulate fraction was indicative of 
norepinephrine bound in vesicles at the terminal sites of sympathetic 
nerves. The report by Hift and Campos (68) was confirmed independently 
by Dahlstrom and Zetterstrom (30) using a different technique to measure 
catecholamines. Experiments employed another modified Wiggers 
procedure: arterial pressure reduced to 35 mmHg, maintained until 40% 
of the bled volume was reinfused, and followed until death ensued 2 to 4 
hours later. Norepinephrine was estimated in the dog spleen by the 
histochemical fluorescent technique of Falck and Hillarp (39). The 
fluorescent method allowed visualization of sympathetic postganglionic 
fibers and their terminal endings as a green fluorescent light. The 
specificity of the technique was good, but allowed only qualitative 
assessment of norepinephrine content. Sympathetic nerve terminals of 
shocked dog spleens were shown to be depleted of norepinephrine. The 
fluorescence was shown to be associated with what was generally accepted 
to be adrenergic nerve terminals. Acute denervation of the spleen 
protected against the depletion of fluorescence during shock. Chronic 
denervation (4 weeks prior to the experiment) eliminated all 
norepinephrine fluorescence in the spleen and also protected against 
gross anatomic abnormalities associated with hemorrhagic shock. Thus, 
the norepinephrine depletion that occurred during hemorrhagic shock has 
been shown using different types of measurement to involve depletion of 
norepinephrine from sympathetic nerve terminals rather than from some 
other source (i.e. interstitium, cardiac muscle tissue, etc.). 
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Thus, norepinephrine depletion from various sympathetically 
innervated organs has been demonstrated in hemorrhagic models of shock. 
The depletion has been localized to the sympathetic nerve terminals. 
The difference in the degree of depletion and the number of organs that 
it encompasses is most readily explained by the different animal species 
and hemorrhagic protocols that have been studied. Most of the 
biochemical techniques for catecholamine measurement were variations of 
the trihydroxyindole fluorescent technique. Because each study used 
subjected to the same tissues from 
biochemical 
non-hemorrhaged 
technique, the 
control animals 
catecholamine analysis is probably not a 
source of difference for results obtained in the above studies. 
b.) Mechanisms of Hemorrhage-induced Norepinephrine Depletion 
Other experiments addressed the consequences and mechanisms of 
norepinephrine depletion during hemorrhagic shock. Extensive 
investigation of the depletion phenomenon was performed in the 
laboratories of Fine. Zetterstrom, Palmerio, and Fine (164) subjected 
adult white rabbits and mongrel dogs to both reversible and irreversible 
shock. Experiments with rabbits addressd the two types of hemorrhagic 
shock. Results showed that hearts, livers, and spleens of reversibly 
shocked rabbits had significantly reduced levels of norepinephrine (42%, 
45%, and 60% respectively, compared to controls). The reduction was 
proportional to the severity of shock. Therefore, irreversible shock 
caused a greater reduction in cardiac, liver, and spleen norepinephrine 
content (34%, 36%, and 51% of respectively, compared to controls). 
Experiments using dogs had similar outcomes. Both hemorrhagic -protocols 
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resulted in decreased norepinephrine content of hearts, livers, and 
spleens; the depletion vas again proportional to the severity of the 
hemorrhagic insult. 
norepinephrine to 
Reversible shock reduced cardiac, liver, and spleen 
39%, 84%, and 76% of control, respectively; 
irreversible shock in dogs further reduced norepinephrine content in the 
same tissues to 36%, 32%, and 32% of control, respectively. A local 
anesthetic was applied to the splanchnic nerves and celiac ganglia of an 
additional group of dogs prior to six hours of hemorrhagic shock. The 
hearts of .these animals (innervated) contained reduced levels of 
norepinephrine compared to controls; livers and spleens (effectively 
denervated by the anesthetic) showed no reduction. These data 
indicated: 1) peripheral tissue norepinephrine content of dogs and 
rabbits in hemorrhagic shock decreased and 2) blockade of the nervous 
supply to the liver and spleen of dogs in hemorrhagic shock resulted in 
normal content of norepinephrine. The authors attributed the 
norepinephrine-sparing effect of denervation to both a decrease in the 
stimulus for release and an increase in blood flow to the denervated 
organs leading to better oxygenation and thus better metabolic function 
of peripheral nerve endings. 
neural mediation and did 
stimulation. Previously, 
Therefore, the depletion was dependent on 
not occur in the absence of sympathetic 
the same group of investigators (114,165) 
showed that acute denervation (surgical) or blockade (application of 
dibucaine in oil to the celiac ganglia) of the sympathetic nerves to the 
splanchnic organs protected against tissue injury and reduced lethality 
in hemorrhagic shock as well as preventing norepinephrine depletion. 
They concluded that the release of norepinephrine from the storage sites 
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was the critical factor in development of the-shock syndrome rather than 
the absolute content of norepinephrine in the nerve terminals of 
peripheral tissues. The conclusions are similar to their findings 
during endotoxin shock in the dog (114,164,165). 
The report of Farnebo and Hamberger (40) attempted to assess the 
amount of reuptake and stimulated release of norepinephrine that 
occurred in tissues isolated from shocked rats. Either a decreased 
norepinephrine reuptake or an increased norepinephrine release per 
stimulus is consistent with the depletion of norepinephrine from tissues 
of animals undergoing high sympathetic drive. Isolated irises (where 
norepinephrine depletion did not occur) and isolated brain slices (where 
norepinephrine depletion did occur) were tested. Results indicated that 
3H-norepinephrine uptake into irises incubated in vitro from shocked 
rats was no different from controls. However, brain slices from shocked 
rats took up significantly less (14%) 3H-norepinephrine than their 
control counterparts. Release of 3H-norepinephrine from both groups of 
tissues demonstrated no hemorrhage-induced changes. 
c.) Absence of Norepinephrine Depletion during Hemorrhage 
It must be noted that norepinephrine depletion has not been 
shown to occur in all models of hemorrhagic shock. Glaviano and Klouda 
(53) demonstrated no differences in left ventricular norepinephrine 
content between alpha chloralose-anesthetized dogs bled to 40 mmHg for 
four hours and sham-operated time-matched controls. The authors 
attributed the results to the open-chested preparation and the-extensive 
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surgical procedures performed on both shock and control dogs. They also 
mentioned the species difference between this and their earlier studies 
in the rabbit. Harrison, Chidsey, and Braunwald (64) demonstrated no 
depletion of atrial norepinephrine in chloralose-anesthetized dogs bled 
to an arterial pressure of 50 mmHg for four hours. However, they 
demonstrated that the effect of a tyramine-induced pressor response was 
reduced greater during shock than a norepinephrine-induced pressor 
response. Radiolabeled norepinephrine release experiments demonstrated 
that the amount of norepinephrine released by tyramine was reduced 
during shock even though the norepinephrine content was unchanged. They 
speculated that the lack of norepinephrine depletion may have been due 
to a decrease in a small portion of the norepinephrine store releasable 
by tyramine, with no change in overall tissue content. 
Thus, the evidence for depletion of norepinephrine from tissues 
of animals in hemorrhagic shock is extensive, although in some models, 
most notably the anesthetized dog, the depletion is equivocal. The 
results of Farnebo et al. (41) indicated that differences occurred in 
sympathetic drive between the anesthetized and unanesthetized rat 
hemorrhagic preparation. Additionally, it should be realized that the 
two preparations in which no norepinephrine depletion was observed 
(53,64) were the only reports using chloralose anesthesia. Therefore, 
not only the presence of anesthesia but also the type of anesthesia may 
be responsible for the differences in norepinephrine depletion that have 
been observed during hemorrhage. It is also important to realize that 
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the underlying mechanism responsible for the depletion during hemorrhage 
has not been fully elucidated and warrants further study. 
3. MECHANISMS OF NOREPINEPHRINE DEPLETION IN ENDOTOXIN SHOCK 
Considering the numerous reports of sympathetic hyperactivation 
and norepinephrine depletion during endotoxic shock, there exists a 
paucity of information concerning the mechanism of depletion. 
Investigations by Fine and coworkers that have already been reviewed 
indicated that the depletion of norepinephrine from splanchnic tissues 
was neurally mediated (114,164,165). Thus, surgical section or 
anesthetic infiltration of the splanchnic nerves protected against 
catecholamine depletion. If endotoxin had a direct effect to release 
catecholamines from neurons without neural input, denervation would not 
have had such an effect. The following studies have further 
investigated the depletion phenomenon and are pertinent to the design of 
the proposed experiments. 
Bhagat et al. (7) tested atrial strips from endotoxic guinea 
pigs (2 to 3 mg/kg) for responsiveness to sympathetic stimulation. 
Generated isometric tension was recorded from isolated, 
Tyrode-superfused, 
(concentration of 
left atrial strips. Dose-response curves 
drug versus increase in force generated, reported as 
per cent of maximal response) were generated for norepinephrine and 
tyramine. A 50% of maximal effective dose (ED50) was calculated for 
each experiment. The ratio of ED50 for endotoxic preparation~ to the 
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ED50 for control preparations was defined as the sensitivity ratio. 
Thus, a sensitivity ratio of greater than 1.00 indicated decreased 
sensitivity of endotoxic preparations compared to controls; a ratio less 
than 1.00 indicated increased sensitivity of endotoxic preparations 
compared to controls. Endotoxic pigs were killed from one to forty-two 
hours after endotoxin. Atrial tissue from endotoxic guinea pigs was 
less sensitive to norepinephrine than tissue from control animals. The 
sensitivity ratio had increased by one hour after endotoxin (1.91); 
lowest sensitivity to norepinephrine was measured at 18 hours after 
endotoxin (sensitivity ratio of 4.00). By 42 hours after endotoxin 
challenge, the sensitivity ratio had returned to control levels (1.05). 
Results were shown for response to tyramine in preparations from control 
and one hour post-endotoxin guinea pigs. The sensitivity to tyramine 
was also decreased in the endotoxic tissue (sensitivity ratio: 1.8). 
The authors hypothesized that increased neuronal reuptake may have been 
responsible for the results in the endotoxic tissue. Increased reuptake 
would inactivate the effect of exogenous catecholamines (decreased 
sensitivity to norepinephrine) as well as locally released 
norepinephrine (decreased sensitivity to tyramine). This hypothesis was 
tested by incubating atria from control and endotoxic guinea pigs with 
3H-norepinephrine for 30 minutes. Tissues were then rinsed and analyzed 
for 3H-norepinephrine. Results showed that labeled norepinephrine was 
actually reduced in atria from endotoxic guinea pigs (760 ~ 25 dpm/mg; 
mean + S.E.M.) compared to controls (1150 ~ 43 dpm/mg). Dose-response 
curves for norepinephrine were also generated after cocaine treatment. 
No differences between groups of tissues were reported: Cocaine 
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increased the sensitivity to norepinephrine by 18-fold in control and 
15-fold in endotoxic preparations. Situations in which decreased 
reuptake of norepinephrine occur should result in decreased sensitivity 
to cocaine. No statistical analysis was made (factoral analysis of 
variance would have been appropriate) to test the differences between 
18- and 15-fold sensitization to norepinephrine after cocaine. 
Additional studies were conducted that demonstrated similar 
l~ngth-tension relationships between control and endotoxic preparations. 
Thus, decreased sensitivity to norepinephrine and tyramine were not 
ascribed to differences in physical characteristics between the two 
groups. The conclusions were that endotoxin pretreatment: 1) decreased 
atrial sensitivity to norepinephrine, 2) did not affect release (or at 
least the tyramine-releasable fraction) of norepinephrine because the 
sensitivity ratio was similar for norepinephrine and tyramine, and 3) 
did not affect uptake of norepinephrine into nerve terminals because of 
similar sensitivity to cocaine in both groups. Because of reduced 
3H-norepinephrine accumulation in endotoxic tissues and similar effects 
of cocaine in both groups, it was speculated that a reserpine-like 
effect may have occurred in endotoxic preparations: norepinephrine was 
transported as usual into nerve terminals, but was then metabolized 
rather than stored intact as norepinephrine. This hypothesis is 
possible, but the method used for norepinephrine isolation (elution from 
acid-washed alumina columns) did not exclude the monoamine oxidase 
end-product DOPEG (3,4-dihydroxyphenylglycol) from the material that was 
counted for radioactivity. Therefore, even if norepinephrine was 
metabolized within the nerve terminal by monoamine oxidase, the DOPEG as 
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well as the norepinephrine would have been measured, resulting in 
similar amounts of tritium recovered in both control and endotoxic 
preparations. Although no measurements of atrial norepinephrine content 
were made, the study investigated norepinephrine reuptake, depression of 
which is a possible mechanism for norepinephrine depletion. In fact, 
Bhagat and Friedman concluded in an earlier paper (6) that under normal 
conditions, reuptake may not play a significant role in maintenance of 
cardiac catecholamine levels; constant levels were dependent on 
synthesis. However, und~r conditions of high sympathetic nerve 
activity, reuptake was important in supplementing synthesis to maintain 
constant norepinephrine levels. 
Additional studies have investigated the process of 
norepinephrine reuptake during endotoxicosis in various animal models 
(120,123). Pohorecky et al. (120) in the study that documented 
norepinephrine depletion, assessed norepinephrine uptake and metabolism 
in endotoxic rats. Animals were injected intravenously w1th 
3H-norepinephrine one hour after intraperitoneal endotoxin. Rats were 
killed ten minutes, one, and four hours later. Spleens, hearts, and 
adrenals were analyzed for 3H-norepinephrine. The method for analysis 
was similar to that of Bhagat et al. (7), and did not exclude deaminated 
metabolites of norepinephrine. Results indicated in all three tissues 
examined that labeled catechols were present in higher concentrations 
in tissues from endotoxic rats compared to controls. By four hours 
after 3H-norepinephrine injection the groups were reversed and tissues 
from control rats contained greater labeled catechols compared to 
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tissues from the endotoxic group. The results were interpreted to 
indicate that endotoxin increased the uptake and accelerated the 
turnover of the catecholamine. Increased norepinephrine reuptake is not 
consistent with norepinephrine depletion from tissues. However, the 
measurement was.made early after endotoxin (one hour), prior to the time 
when norepinephrine depletion was observed in the model. It has been 
proposed that norepinephrine reuptake increases during periods of high 
sympathetic activity (17,50) to conserve the greater amounts of 
norepinephrine that are liberated. It is evident from an earlier 
discussion that plasma catecholamine levels are increased after 
endotoxin administration, although they were not measured in the present 
study. Increased concentrations of circulating catecholamines may be a 
partial explanation for the increased reuptake measured. 
Rao et al. (123) studied the effects of endotoxin on 
hemodynamics and norepinephrine metabolism in the dog. 
3H-norepinephrine was administered to dogs 30 minutes before endotoxin 
(2 mg/kg) injection. Blood samples drawn from the femoral artery were 
collected 5 minutes before and 3, 5, and 30 minutes after endotoxin 
administration and analyzed for 3H-norepinephrine. Two hours after 
endotoxin, spleens, ventricles, left atria, right atria, adrenals, and 
kidneys were analyzed for 3H-norepinephrine and 3H-normetanephrine. 
3H-norepinephrine was measured by a similar technique to Bhagat et al. 
(7) and did not exclude deaminated metabolites. However, aliquots of 
the sample were analyzed for the catechol-o-methyl transferase (COMT) 
end-product, normetanephrine, by a further purification step. Two hours 
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after endotoxin 3H-norepinephrine was increased in spleens and adrenals, 
but remained unchanged in the other organs sampled. The data were 
interpreted to indicate that norepinephrine reuptake was increased in 
the endotoxic dog. However, neuronal reuptake of tracer doses of 
norepinephrine occurs rapidly (within 10 minutes). In the experiment, 
the time lapse between 3H-norepinephr~ne injection and tissue sampling 
was extremely long (150 minutes). Furthermore, endotoxin was injected 
long after norepinephrine reuptake was complete. The results may be 
more indicative of endotoxin modulation of catecholamine metabolism 
after reuptake. In all tissues 3H-normetanephrine was increased, 
suggesting that metabolism of norepinephrine was accelerated during 
endotoxicosis. However, normetanephrine is formed by an enzyme present 
only outside the sympathetic nerve terminal. Thus, the increased 
catabolism is indicative of extraneuronal metabolism. Finally, 
3H-norepinephrine was decreased compared to control in plasma of 
endotoxic dogs at all times sampled; 3H-normetanephrine was increased 
above control in the endotoxic dog at all times tested. These results 
were also interpeted to indicate that an increased release and 
metabolism of norepinephrine took place in the endotoxic dog. 
Norepinephrine depletion may occur more readily if release is 
increased. A modulatory effect on the presynaptic terminal to release 
more norepinephrine per nerve impulse may be partially responsible for 
depletion of norepinephrine from nerve terminals. Studies (115,117,118) 
using electrophysiological techniques investigated in vitro effects of 
endotoxin to alter presynaptic and postsynaptic events. Experiments 
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performed on neuromuscular preparations of crayfish indicated that in 
vitro addition of endotoxin increased the frequenc7 of miniature 
-------
excitatory postsynaptic potentials, decreased facilitation, and 
increased the evoked excitatory postsynaptic potential without changing 
membrane resistance (115). The results were consistent with the 
hypothesis that endotoxin acted on the presynaptic nerve terminal to 
increase the amount of transmitter substance released in response to an 
applied stimulus. Electrophysiological experiments that tested the 
effect of either protein-contaminated endotoxin (crude extract) (117) or 
RNA-free lipopolysaccharide (purified extract) (118) on frog 
neuromuscular junctions have been performed. Addition of the crude 
extract to the in vitro preparation first induced an increase in 
spontaneous miniature endplate potential frequency followed by a 
decreased frequency with no change in miniature endplate potential 
amplitude. The effect was calcium sensitive and suggested that 
endotoxin altered calcium conductance channels in the presynaptic 
terminal membrane. Use of the purified extract depressed spontaneous 
and evoked transmitter release in the same model. These studies 
demonstrated that endotoxin had direct neurotoxic effects. A similar 
modulation of spontaneous or nerve-stimulated release may have occurred 
during endotoxicosis in the rat to accelerate norepinephrine turnovers 
and increase sympathetic stimulation to neuroeffector sites. Thus, 
local effects of endotoxin or its mediators on peripheral neurons may 
affect spontaneous or evoked norepinephrine release. These hypotheses 
are consistent with findings from Fine and associates (114,164,165) that 
demonstrated the protective effect of denervation on peripheral tissue 
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norepinephrine depletion during endotoxicosis. Although endotoxin may 
have an effect to increase nerve-stimulated release of norepinephrine, 
the effect would not be functionally evident if the nervous supply was 
cut and no nerve activity was present. 
As can be surmised, relatively little information is present in 
the literature that addresses mechanisms for norepinephrine depletion 
during endotoxicosis. This is surprising in light of the protective 
effect that blunting the sympathetic response has to pathologic changes 
and lethality associated with endotoxic shock. 
CHAPTER III 
RATIONALE AND SPECIFIC AIMS 
Two general themes regarding sympathetic nervous system function 
during endotoxic shock are evident after review of the related 
literature. One is that the sympathetic nervous system is activated, 
indeed, over-activated during endotoxicosis. A second is that the 
massive, generalized, sympathetic tone is detrimental to the organism in 
endotoxic shock. Thus, extensive work has implicated the sympathetic 
nervous system in the pathogenesis of endotoxic shock. The present 
experiments focus on one manifestation of sympathetic activity during 
endotoxicosis: norepinephrine depletion from peripheral nerve 
Experiments of Fine and colleagues (114,164,165) terminals. 
demonstrated that norepinephrine depletion was avoided if the 
sympathetic nerve supply to an organ was interrupted before either 
endotoxin or hemorrhage. Furthermore, splanchnic denervation was 
associated with reduced histopathologic changes in the splanchnic organs 
during shock as well as a reduced overall lethality. These types of 
experiments demonstrated that the depletion was important because it 
represented the transfer of excessive amounts of norepinephrine from 
storage sites in the nerve terminal to active sites accessible to 
receptors in the periphery. Thus, characterization of norepinephrine 
depletion and elucidation of the mechanisms causing it are essential 
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steps toward reversal or prevention of the functional hyperactivity of 
the sympathetic nervous system associated with endotoxic shock. 
From the discussion of physiological maintenance of tissue 
norepinephrine levels (as summarized in Figure 1) several points become 
apparent. First, for a massive decrease in norepinephrine levels to 
occur the normal relationship between the five listed processes must 
change or an additional "depleting" process (such as a direct effect of 
endotoxin to release norepinephrine) must occur. Second, if a change in 
an existing process occurred, the net effect would be an increase in one 
or more processes that decrease content (sympathetic drive, 
intraneuronal degradation) and/or a decrease in one or more processes 
that increase content (biosynthesis, neuronal reuptake). Third, from 
the conclusions of denervation experiments the depletion should be 
dependent on mechanisms involved subsequent to nerve stimulation, 
because denervation eliminated the depletion. An additional conclusion 
is that endotoxin does not act directly on sympathetic nerve endings to 
increase their permeability and cause release of norepinephrine in the 
absence of nerve stimulation. This would be an example of an additional 
"depleting" process mentioned above. 
What mechanisms that may cause depletion of norepinephrine are 
consistent with the findings of the existing literature? Increased 
release of norepinephrine is a possible consequence of endotoxicosis and 
may occur because of two effects: increased sympathetic nerve activity 
and/or increased release of transmitter per nerve stimulus. Increased 
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release is consistent with the elevation of plasma catecholamine levels 
and depression of tissue catecholamines during endotoxic shock. 
Increased sympathetic activity and release of catecholamines is also 
consistent with baroreceptor activation that would be expected during 
the hypotensive periods after endotoxin administration. 
Another hypothesis for norepinephrine depletion which is 
consistent with the sympathetic neural manifestations of endotoxicosis 
is depression of neuronal reuptake of norepinephrine. Decreased 
recovery of released norepinephrine would lead to increased circulating 
levels of the catecholamine. Because reuptake conserves much of the 
released norepinephrine, depression of the process sensitizes the nerve 
terminals to depletion of the neurotransmitter. Because the depletion 
associated with decreased reuptake is dependent on release of the 
transmitter, blockade of the nervous supply to the tissue would also 
protect against the depletion. 
Increased intraneuronal degradation is also a possibility 
consistent with norepinephrine depletion. This could occur by either an 
increased activity or amount of monoamine oxidase or by a reduction of 
the intraneuronal vesicular reuptake process. However, the singular 
effect of increased degradation is not consistent with some of the 
neural manifestations of endotoxicosis. No increased circulating 
catecholamine levels would be expected. In fact, a decrease may occur 
because of an overall decrease in release subsequent to depressed tissue 
levels. The mechanism of singular depression of catecholamine 
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biosynthesis is also consistent with tissue depletion of norepinephrine 
and inconsistent with the elevated circulating catecholamines of 
endotoxicosis. Again, depressed synthesis would be expected to decrease 
release subsequent to depressed tissue levels. 
Thus, the major candidates for norepinephrine depletion during 
endotoxicosis are increased release (by increased sympathetic activity 
or modulation of nerve-stimulated release) and decreased neuronal 
reuptake of norepinephrine. Minor or contributory candidates that may 
synergize with the major proposed mechanisms are depressed biosynthesis 
and increased intraneuronal degradation. 
In light of the existing literature on the sympathetic nervous 
system during endotoxic shock and subsequent interpretations of the 
studies, the following specific aims are presented for design of the 
present experiments: 
1. Demonstrate norepinephrine depletion in an endotoxic rat model and 
further characterize the conditions under which it occurs. The 
spleen and heart will be used for the following reasons: Both organs 
contain dense sympathetic innervation and relatively high 
norepinephrine content and are therefore appropriate for depletion 
studies. Both organs have been used previously in similar 
investigations and their further study would facilitate 
interpretations in light of the existing literature. The heart and 
spleen are both circulatory organs - the heart is representative of 
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pumping processes vith most innervation being directly to myocardial 
cells. The spleen is representative of the vascular or resistance 
compartment vith most of its innervation on vascular tissue rather 
than parenchymal or structural cells. 
2. Assess sympathetic activity in the endotoxic model by a more 
reliable and direct method than previously used. The method of 
choice is norepinephrine turnover measurement in hearts and spleens 
by the 3H-norepinephrine decay technique. This procedure reliably 
reflects sympathetic activity to the organ in question (12,26,27). 
Additionally, it quantitates sympathetic activity by a non-invasive 
method in an unanesthetized animal, thus eliminating two of the 
problems of earlier studies. Analysis of norepinephrine turnovers 
also reveals semi-quantitative data concerning norepinephrine 
synthesis during the period of turnover measurement. 
3. Measure neuronal reuptake of norepinephrine in hearts and spleens of 
endotoxic animals that display norepinephrine depletion. Use of 
radiolabeled norepinephrine either injected into the circulation or 
incubated vith tissues in vitro vill allow tracing the amount of 
norepinephrine taken up by tissues. It is important to perform both 
in vitro as vell as in vivo studies because reuptake after 
norepinephrine injection is dependent on circulatory distribution of 
the bioamine. Distribution of blood flow has been shown to change 
dramatically in the endotoxic state (42,83,159,160). From the in 
vitro studies some additional qualitative information may be 
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obtained regarding intraneuronal degradation of norepinephrine by 
assessing the amount of radiolabeled norepinephrine retained in its 
unmetabolized state. 
The aims of the present research are founded on a logical 
extension of the existing literature and are designed to answer 
important questions regarding sympathetic function during endotoxic 
shock. Execution of the experiments should enhance and expand the 
understanding of the mechanisms of norepinephrine depletion as well as 
promote the development of interventions to reduce sympathetic 
hyperactivity in endotoxic shock and its clinical counterparts, sepsis 
and septic shock. 
CHAPTER IV 
METHODS 
A. Animals and Care 
Male Holtzman rats of 300-350 gm body weight were used 
throughout these studies. Prior to experimentation all rats were 
maintained in the animal research facility for a minimum of 7 days after 
receipt from the supplier (Holtzman Company, Madison, Wisconsin) to: 1) 
adjust to a 12 hr light-dark cycle (light from 0700 hr to 1900 hr, 
central daylight time), and 2) recover from the stress of shipping. 
Rats were housed four per cage (cage dimensions: 16" length, 9.5" width, 
and 7" depth) except where noted to be housed individually (cage 
dimensions: 7" length, 9.5" width, and 7" depth). Ambient temperature 
was approximately 72° F and relative humidity was 30% to 50%. Animals 
were maintained on Purina rat chow and tap water ad libitum. Fasting 
was induced by removing food but not water at 4 to 6 pm on the day 
preceding the experiment. Cages were of a hanging variety with wire 
mesh floors so that rats did not have access to their own feces during 
the evening of the fast. Thus, rats were post-absorptive by the start 
of experiments on the following morning. 
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B. Shock Model 
Endotoxins derived from the outer cell walls of gram-negative 
bacteria have been widely used experimentally to model septic shock. 
The present experiments employed a simple, reproducible model of 
endotoxic shock in the rat. The biological activity of an endotoxin 
isolated from the cell walls of gram-negative bacteria depends upon the 
cell wall constituents associated with it. The preparation of endotoxin 
used in these experiments was Salmonella enteritidis endotoxin prepared 
by the Boivin method (extraction by trichloroacetic acid). The toxin 
thus obtained was primarily lipopolysaccharide in complex with protein 
from the cell wall. Endotoxin was purchased from Difeo Laboratories, 
Detroit, Michigan. The endotoxin was prepared daily in 0.9% saline. 
Fasted rats under light ether anesthesia were injected with endotoxin (5 
mg/rat or about 14 to 17 mg/kg, except where noted) intravenously via 
the dorsal vein of the penis. All injections were performed between 
0700 hr and 1000 hr to minimize the effects of diurnal sensitivity to 
endotoxin. This regimen induced a 60% to 80% lethality at 24 hours 
(seasonal variation in lethality occurred). Each batch of endotoxin was 
checked for potency prior to experiments. Control rats under ether 
anesthesia were injected intravenously with 0.9% saline. The rats were 
returned to their cages (allowed access to water but not food) and 
followed until just prior to death (evidenced by loss of the righting 
reflex) if it occurred by 5 hours post-endotoxin; rats still alive 5 
hours post-injection were sacrificed at that time. 
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The shock state progresses at different rates in individual 
animals. Use of the present protocol allowed study or both mildly and 
severely shocked rats. Because glucoregulatory dysfunction of endotoxic 
shock results in a progressive decline of plasma glucose after an 
initial hyperglycemia (45), the plasma glucose concentration was used as 
an indicator of the severity of the shock state. Mild or early phase 
shock is indicated by a plasma glucose greater than 40 mg/dl; severe or 
late phase shock is indicated by a plasma glucose less than 40 mg/dl. 
All endotoxic rats were, therefore, divided into mild or severe shock on 
the basis of their plasma glucose levels at the time of sacrifice. 
C. Plasma Glucose Measurement 
Rats were sacrificed by decapitation with a guillotine (Stoetler 
Apparatus Company). Mixed arterial and venous blood samples were 
collected from the neck wound in 250 ul heparin-treated microfuge tubes. 
The blood was stored on ice for short periods (5 to 30 minutes) before 
centrifugation in a Beckman Model 152 microfuge. Samples were then 
frozen until glucose analysis was performed (usually within one week). 
Plasma glucose was measured on a Yellow Springs Instrument Model 
23A Glucose Analyzer. The instrument utilizes an oxidase enzyme 
hydrogen peroxide probe developed by Dr. Leland Clark. The principles 
on which the analyzer operates are as follows: D-Glucose and oxygen are 
converted to gluconic acid and hydrogen peroxide via the enzyme glucose 
62 
oxidase (reaction 1). The hydrogen peroxide is then oxidized by a 
platinum electrode (the anode) to liberate hydrogen ions, oxygen, and 
electrons (reaction 2). A silver cathode then reduces the oxygen and 
tiydrogen ions to water (reaction 3). The oxidation or hydrogen peroxide 
creates a current that is proportional to the amount of glucose in the 
sample. 
In practice, the glucose probe is the platinum anode covered by 
a two-layered membrane. The outer membrane is composed or a 
polycarbonate material that will allow diffusion of small molecules but 
will exclude enzymes. The inner membrane is composed of a cellulose 
acetate material that will pass hydrogen peroxide, oxygen, water, and 
salts, but will exclude glucose, ascorbic acid and other substances that 
may interfere with the analysis. The glucose oxidase is immobilized 
between the membranes in a thin layer of resinous material. Thus, 
glucose in the sample diffuses through the outer membrane, is oxidized 
to hydrogen peroxide by the glucose oxidase, and then diffuses through 
the inner membrane for the reaction at the platinum electrode. The 
buffer in which the glucose is diluted contains a catalase that destroys 
any hydrogen peroxide that diffuses back into the sample chamber. The 
electrode system acts as a polarograph. The platinum electrode is 
polarized at 0.7 volts with respect to the cathode to maximize the 
specificity of reaction 3 for oxidation of hydrogen peroxide. The 
polarization voltage and the inner membrane effectively filter out all 
interfering substances. The current necessary to maintain a constant 
voltage (0.7 volts) across the electrodes is then proportional to the 
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amount of hydrogen peroxide oxidized, and hence the amount of glucose 
present in the sample. Therefore, the glucose measurement is dependent 
on the amount of glucose in the sample, and not on its concentration. 
For accurate measurements it is critical to maintain constant sample 
size. This method has been shown to give comparable results as other 
methods (72). The instrument was routinely calibrated against known 
standards and checked for linearity before sample analysis. All samples 
were analyzed in duplicate, and an average of the results was calculated 
for the final glucose concentration. 
D. Tissue Catecholamine Measurement 
Tissue levels of catecholamines (norepinephrine and epinephrine) 
were estimated by the trihydroxyindole fluorometric assay according to 
Crout (29). According to this method, the catecholamines are purified 
by the acid-washed alumina method first used by Shaw (135) and later 
modified by Lund (100). The fluorometric analysis has been adapted to 
the Autoanalyzer by Jellinek et al. (79). The following section 
includes a description of these procedures as well as an illustration of 
typical fluorometric data. 
1. TISSUE SAMPLING AND STORAGE 
After decapitation, hearts and spleens were rapidly removed and 
blotted to remove excess blood. Tissues were frozen rapidly by 
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compression between a pair of Wollenberger tongs precooled in liquid 
nitrogen and immediately immersed in liquid nitrogen to accelerate the 
freezing process. Spleens were frozen intact, without removal of the 
capsule. Hearts were frozen with only the ventricles compressed between 
the faces of the tongs. The atria were cut away before immersion in 
liquid nitrogen. Thus, all cardiac catecholamine levels reflect average 
ventricular (left and right) content of the bioamines. The total time 
to remove and freeze the samples was about two minutes from the time of 
decapitation. Frozen tissues were subsequently stored in liquid 
nitrogen until analyzed (typically one to two weeks). A timed storage 
study in this laboratory demonstrated that degradation of catecholamines 
during storage time was negligible. 
2. CATECHOLAMINE PURIFICATION 
Tissues were weighed frozen on a Roller-Smith balance and placed 
in 10 ml of 10% trichloroacetic acid. As tissues thawed, they were 
homogenized with a Brinkman Kinematica Polytron for 20 seconds at full 
speed. The homogenate was filtered on fluted Sharkskin filter paper; 
the precipitated protein was discarded. 
Five ml of the filtrate was transferred to a 50 ml Erlenmeyer 
flask containing the following: 1) 10.0 ml of cold 0.2 M sodium acetate 
(NaOAc), 2) 0.5 ml of cold 0.2 M ethylenediaminetetraacetate (EDTA), and 
3) drop of 1% phenolphthalein. The solution was titrated with cold 
0.5 N NaOH to pH s.4, indicated by a pale pink color. The solution was 
r 
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poured onto a glass column containing 0.5 gms of acid-washed alumina. 
columns were custom-made and were composed of a 50 ml reservoir at the 
top, below which was a 15 cm column (I.D. 0.5 cm). At the lower end of 
the column a constriction allowed placement of glass wool that acted as 
a trap for the alumina. Flow rate was typically one to two ml/min. At 
pH 8.4 good specificity was obtained for adsorption of the negatively 
charged catecholamines onto the positively charged alumina. Ten ml of 
cold distilled water were added to the column as a rinse. Finally, the 
catecholamines were eluted from the column by addition of 5 ml of 0.2 M 
acetic acid. The eluates were sealed with parafilm and stored at 5° C 
until analyzed (within one to two weeks). The catecholamines have been 
shown in this laboratory to be stable over this period. Recovery of 
norepinephrine from the columns was routinely 80%. Values were reported 
as uncorrected for the per cent recovery. 
3. CATECHOLAMINE ANALYSIS 
After mixing with slightly acidic sodium acetate buffer (NaOAc + 
EDTA), the eluate was analyzed for catecholamines by oxidation of the 
norepinephrine and epinephrine to their respective 2-iodo aminochrome 
derivatives with iodine. Subsequent treatment with strong NaOH (30%) 
caused tautomerization of the aminochromes to fluorescent derivatives of 
3,5,6-trihydroxyindole. Because the indoles were unstable in the 
presence of oxygen, ascorbic acid was added to remove dissolved oxygen 
from the system. The flow diagram for adaptation of this procedure to 
an automated process on the Technicon Autoanalyzer is illustrated in 
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Figure 2. Concentrations of the reagents were as follows: 0.2 N acetic 
acid, 30.0% NaOH, 1.0 M NaOAc (either at pH 6.5 or 3.5), 0.1 N I 2 , 0.05 
N thiosulfate, and 7.5 mM ascorbate. The fluorometer was outfitted with 
a flow-through cell and interfaced with a Beckman strip chart recorder. 
The primary fluorometer filter (47B) was of a narrow pass variety at 436 
nm. The secondary filter (2A-12) was a sharp cutoff filter above 510 
nm. 
Differential estimation of norepinephrine and epinephrine was 
accomplished by carrying out the oxidation to the aminochrome with 
buffer at pH 3.5 and pH 6.5. At the less acidic pH both bioamines are 
oxidized to the aminochrome stage; at the more acidic pH only 
epinephrine is significantly oxidized. In practice, the differentiation 
of catecholamines was performed by analyzing the sample four times in 
the following modified conditions: 1) NaOAc at pH 6.5, 2) NaOAc at pH 
3.5, 3) NaOAc at pH 6.5 containing 50 ng/ml norepinephrine, and 4) NaOAc 
at pH 6.5 with the ascorbate and distilled water reagent tubes reversed. 
Under condition 1, both norepinephrine and epinephrine are oxidized, 
while under condition 2 only epinephrine is oxidized. The fluorometric 
peak height in condition 2 is proportional to the epinephrine 
concentration in the sample; the difference between the peak heights in 
condition and 2 is proportional to the norepinephrine concentration. 
Condition 3 is an internal standard that raises the background level of 
norepinephrine and allows for estimation of fluorescent quench that 
occurs. Condition 4 introduces the ascorbate into the sample mixture 
after oxygen has destroyed the 3,5,6-trihydroxyindole derivatiVe of the 
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Figure 2. 
Schematic diagram illustrates the tubing organization for 
catecholamine analysis on the Autoanalyzer. Numbers along right margin 
indicate the inner diameter (inches) of tubes that draw the indicated 
reagents. Because the roller pump rotates at a constant velocity, the 
tubing diameter regulates the flow. 
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catecholamines. This measurement is a blank that yields background 
fluorescence 
concentration 
epinephrine 
acid sample 
in the sample. In addition to unknown samples, one known 
(repeated three additional times) of norepinephrine and 
(referred to as daily standards) as well as a 0.2 M acetic 
(repeated three additional times), the vehicle for the 
catecholamines, was run under the above conditions as standards and 
blank, respectively. Because the fluorometer output describes a linear 
relationship to catecholamine concentration, only one blank and one 
known concentration of norepinephrine and epinephrine are necessary to 
calculate catecholamine concentrations of the unknown samples. 
4. CALCULATION OF NOREPINEPHRINE AND EPINEPHRINE 
Norepinephrine (NE) and epinephrine (E) were calculated for each 
sample by solving the following simultaneous equations: 
(a/b) x !NE! + (c/d) x !E! = peak height of sample at pH 6.5 
(e/b) x !NE! + (f/d) x !E! = peak height of sample at pH 3.5 
where: 
a = peak height of norepinephrine standard at pH 6.5; 
b s concentration of norepinephrine standard; 
c = peak height of epinephrine standard at pH 6.5; 
d = concentration of epinephrine standard; 
e = reading of norepinephrine standard at pH 3.5; 
f s reading of epinephrine standard at pH 3.5; 
!NE! s concentration of norepinephrine in sample; 
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!E! = concentration of epinephrine in sample; 
Note: All peak heights are previously corrected for quench using the 
internal standard. 
The calculations were performed on a PDP-12 computer (Digital 
Equipment Co.). The computer program (FOCAL) is shown in Figure 3. The 
peak heights from the strip chart recorder were entered into the 
computer using the following code letters: 
Standards -
p = NE reading at pH 6.5 NaOAc buffer; 
Q .. NE reading at pH 3.5 NaOAc buffer; 
R = E reading at pH 6.5 NaOAc buffer; 
s = E reading at pH 3.5 NaOAc buffer; 
Samples -
LABEL • Name of sample; 
BLK = Blank reading; 
RED -= Reading at pH 6.5 NaOAc buffer; 
EPI • Reading at pH 3.5 NaOAc buffer; 
STD = Reading using internal standard; 
WT = Weight of tissue; 
An example of the recorder output from the fluorometer for known 
samples is shown in Figures 4 and 5. Nine different concentrations of 
norepinephrine and/or epinephrine were made from stock solutions of 10 
pg/ml and diluted into 0.2 M acetic acid. No mixture was made from 
serial dilutions of another. Nine pairs of samples were run. Figure 4 
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Figure 3. 
FOCAL program used to calculate tissue norepinephrine and 
epinephrine content. 
weight. 
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Figure 4. 
Output from Beckman chart recorder illustrates fluorometric 
peaks from samples run in buffer at pH 6.5. Concentrations of 
norepinephrine (NE) and epinephrine (E) are indicated above the peaks. 
Samples 7-12 contain a mixture of norepinephrine and epinephrine that is 
a total of 60 ng of catecholamine per ml. 
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Figure 5. 
Output from Beckman chart recorder illustrates fluorometric 
peaks from samples run in buffer at pH 3.5. Concentrations of 
norepinephrine (NE) and epinephrine (E) are indicated above the peaks. 
Samples 7-12 contain a mixture of norepinephrine and epinephrine that is 
a total of 60 ng of catecholamine per ml. 
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for samples run with pH 6.5 buffer; Figure 5 
for samples run with pH 3.5 buffer. Bote that 
samples 5 through 14 contained a total catecholamine concentration of 60 
ng/ml (norepinephrine and/or epinephrine). At pH 6.5 both 
catecholamines were oxidized to approximately the same degree. 
Therefore, peak heights 5 through 14 were of similar magnitude. 
However, at pH 3.5 only the epinephrine was significantly oxidized, and 
thus the peak heights were primarily dependent on the concentration of 
epinephrine present in the sample. 
The linearity of the system is shown graphically in Figures 6 
and 7. The peak heights (cm) for the pure epinephrine and 
norepinephrine knowns (15, 30, and 60 ng/ml) were plotted versus their 
concentrations (ng/ml). Additional points were the blank (0 ng/ml) and 
the normal daily standard (50 ng/ml). These two concentrations are the 
two standards used for calibration of a typical analysis. Normal 
unknown data values fall within the extremes of the graphs. Figure 6 
depicts the results for the samples run in pH 6.5 buffer (data from 
Figure 4). Note that norepinephrine oxidation, and hence its 
fluorescence, is marginally greater than for epineprine at this pH. 
Figure 7 represents the data recorded at pH 3.5 (data from Figure 5). 
At this pH epinephrine oxidation and fluorescence is approximately 
twenty times higher than norepinephrine oxidation. Regression lines 
vere calculated from all five data points for each line. The 
correlation coefficient, r, for each of the four lines was greater than 
0.99. The equations for the lines in the form y = m(x) + b are: 
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Figure 6. 
Graph displays the linear response of the fluorometer to 
epinephrine and norepinephrine analyzed in pH 6.5 buffer. The peak 
height (cm) is plotted versus the catecholamine concentration (ng/ml) 
for the raw data of Figure 4. Details of linear regression are in text. 
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Figure 7. 
Graph displays the linear response of the fluorometer to 
epinephrine and norepinephrine analyzed in pH 3.5 buffer. The peak 
height (cm) is plotted versus the catecholamine concentration (ng/ml) 
for the raw data of Figure 5. Details of linear regression are in text. 
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Norepinephrine at pH 6.5: 
Epinephrine at pH 6.5: 
Norepinephrine at pH 3.5: 
Epinephrine at pH 3.5: 
Table I 
analysis system. 
y • o.197x + 0.023, 
y • o.111x + o.oa9, 
y • o.149x + 0.053, and 
y • 0.381x + 0.223. 
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for epinephrine 
illustrated. 
and 5, and 
illustrated). 
FOCAL program 
depicts the repeatability and the accuracy of the 
The actual concentrations of norepinephrine and 
each known sample as well as the calculated values are 
Calculated values were derived from the data of Figures 4 
the respective internal standard and blank runs (not 
Results 
with a 
were calculated using the previously described 
slight modification to account for absence of 
tissue weights and to calculate the output as ng/ml. The calculated 
values are repeatable and extremely close to the actual concentrations. 
5. RECOVERY OF CATECHOLAMINES FROM COLUMN CHROMATOGRAPHY 
All of the catecholamines from the filtrate are not recovered in 
the eluate from the alumina chromatography isolation. The amount of 
recovery is closely related to the preparation of acid-washed alumina 
and the technique by which the catecholamines are isolated. Typically, 
the recovery of catecholamines from the column is 80%, and is highly 
reproducible. The per cent recovery was measured numerous times while 
the technique was initially learned, and was subsequently performed 
every time a new batch of acid-washed alumina was prepared. The 
procedure for checking the per cent recovery is as follows: 
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TABLE I: ACTUAL AND CALCULATED CONCENTRATIONS 
OF NOREPINEPHRINE AND EPINEPHRINE FROM DATA OF FIGURES 4 AND 5 
NOREPINEPHRINE EPINEPHRINE 
(ng/ml) (ng/ml) 
Sam;Ele No. Actual Calculated Actual Calculated 
1 15 15 0 0 
2 15 15 0 0 
3 30 30 0 0 
4 30 29 0 0 
5 60 60 0 0 
6 60 61 0 0 
7 45 43 15 16 
8 45 43 15 16 
9 30 29 30 31 
10 30 31 30 31 
11 15 14 45 45 
12 15 17 45 44 
13 0 -1 60 60 
14 0 -1 60 61 
15 0 0 30 31 
16 0 0 30 31 
17 0 -1 15 16 
18 0 -1 15 16 
Nine different concentration mixtures (norepinephrine and/or 
epinephrine) were made in 0.2 M acetic acid. Two samples (1 and 2, 3 
and 4, etc.) were taken.from each mixture, treated as column eluates, 
and analyzed as described in the text. Therefore, these data did not 
rely on serial dilutions of samples. Data from Figures 4 and 5 as well 
as additional data using an internal standard and blank were used to 
calculate the values with the FOCAL program. 
Several tissues vere ground and pooled to yield about 50 ml of 
filtrate; eight 5 ml samples vere removed. Samples 1-4 were processed 
as described above for catecholamine purification. Samples 5-8 were 
purified after addition of 250 ng of norepinephrine. The result was an 
additional 50 ng/ml in the final 5 ml of eluate. The results of a 
typical per cent recovery are shown on Table II. 
E. 3H and 3H-Norepinephrine Analysis 
For experiments in which 3H-norepinephrine was used, total 3H or 
3H-norepinephrine in tissues was measured as follows: Aliquots (0.5 ml) 
of the protein-free filtrate (in the case of total 3H measurement) or 
the alumina eluates (for 3H-norepinephrine measurement) were dissolved 
in 14.5 ml of PCS scintillation fluor (Amersham). Samples were counted 
for 3H in an Isocap/300 scintillation counter (Nuclear Chicago). 
Quench correction was performed by the standard channels ratio 
method (153). Use of this technique relies on the effect of quench to 
decrease the average pulse height of the 3H energy spectrum; the pulse 
height spectrum will shift toward a lower energy level in a count rate 
versus pulse height graph. A known standard with no quench and with 
various amounts of added quench is counted under two conditions: 1) with 
the window discriminators open only to a 3H channel (A) and 2) with the 
window discriminators open to a full 14c window (B). The ratio of 
channel A to channel B counts is dependent on the amount of pulse height 
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TABLE II. RECOVERY OF NOREPINEPHRINE (NE) FROM COLUMN CHROMATOGRAPHY 
(Explanation of protocol is in text.) 
Substance 
50 ng/ml NE Standard 
50 ng/ml NE Standard 
50 ng/ml NE Standard 
50 ng/ml NE Standard 
Sample 
Sample 2 
Sample 3 
Sample 4 
Sample 5 + NE 
Sample 6 + NE 
Sample 7 + NE 
Sample 8 + NE 
where: standard = A (known) 
sample s B (unknown) 
Peak Height 
6.5 
6.5 
6.6 
6.5 
2.9 
2.9 
2.s 
2.9 
8.2 
8.5 
8.2 
8.0 
sample + NE = C (known + unknown) 
then: 100 x (C - B)/A = per cent recovery 
or: 100 x (8.23 - 2.88)/6.53 = 81.9% recovery. 
Avg Peak Height 
6.53 
2.88 
8.23 
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shift and hence the amount of quench. From the data obtained on known 
activity standards, a standard curve is constructed plotting per cent 
counting efficiency versus ratio of channel A to channel B counts per 
minute. For each experimental sample, the channel count ratio is 
determined and the per cent counting efficiency is determined from the 
standard curve. In practice, a FOCAL program has been written to 
construct a standard curve for each daily run from the commercially 
purchased quenched standards and to correct each sample for its counting 
efficiency and convert it from cpm to dpm. The program is illustrated 
in Figure 8. Minor alterations of the program were made to tailor the 
output to the particular experiment. The specific program depicted was 
used for the in vitro norepinephrine uptake experiments. Efficiency for 
counting 3H in this system was typically 40-45%. All tritium data were 
expressed as dpm per unit of tissue wet weight. 
F. Norepinephrine Reuptake Measurement 
1. IN VIVO REUPTAKE MEASUREMENT 
Norepinephrine reuptake was assessed in vivo by measuring the 
amount of intravenously injected 3H-norepinephrine retained by hearts 
and spleens. Four groups of rats were used: saline-injected controls, 
mild shock rats, severe shock rats, and rats pretreated with the 
specific neuronal reuptake blocker, desmethylimipramine (20 mg/kg) sixty 
minutes prior to the experiment. All rats were injected intravenously 
in the dorsal vein of the penis with small amounts of high specific 
Figure 8. 
FOCAL program used to perform standard channels ratio quench 
correction and calculate 3H, 3H-norepinephrine, and net norepinephrine 
uptake. 
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activity (11 Ci/mmol) L-(7,8-3H)-norepinephrine (20 ~Ci/kg). Therefore, 
rats were killed 
3H-norepinephrine. 
by decapitation ten minutes after injection with 
Hearts and spleens were removed, blotted, and 
and 'H-norepinephrine content as described assayed for norepinephrine 
above. Data were expressed as dpm/gm tissue vet weight. 
Preliminary experiments demonstrated that maximum uptake of 
labeled norepinephrine occurred within ten minutes of its injection. 
Saline control and five hour endotoxic rats were injected with 20 ~Ci/kg 
of 3H-norepinephrine. Animals were selected at random either 5 or 10 
minutes later and decapitated. Hearts and spleens were assayed for 
3H-norepinephrine. In the saline series, there was no difference in 
3H-norepinephrine content of hearts between the 5 minute (12675 ~ 816 
dpm/gm; n•5) and 10 minute (11518 ~ 1142 dpm/gm; n•5) circulation time 
groups. In saline control spleens, the 5 minute group (2168 ~ 151 
dpm/gm; n•4) was no different from the 10 minute group (2315 ~ 309 
dpm/gm; n•5). Similar results were found in tissues from endotoxic 
rats. 
dpm/gm 
(n•10) 
Cardiac 3H-norepinephrine in endotoxic rats was 13871 ~ 929 
(n•10) for 5 minutes of circulation time and 14077 ~ 1254 dpm/gm 
in the 10 minute group. Spleen 3H-norepinephrine in the 
endotoxic group was 1642 ~ 270 dpm/gm (n•10) in the 5 minute group and 
1382 + 359 dpm/gm (n•8) in the 10 minute group. Statistical analysis 
was performed between each set of 5 and 10 minute groups (e.g. spleens 
of saline treated rats sacrificed 5 versus 10 minutes after 
3H-norepinephrine) by an independent Student's t test. No significant 
differences in 3H-norepinephrine content existed between the 5 and 10 
minute circulation time groups for either control or endotoxic rats. 
Thus, for in vivo uptake experiments, tissue sampling at 10 minutes 
after 3H-norepinephrine injection was considered to measure total uptake 
of the labeled amine in both control and endotoxic series of rats. 
2. IN VITRO REUPTAKE MEASUREMENT 
Norepinephrine reuptake was assessed by measuring the amount of 
3H-norepinephrine incorporated in tissue slices incubated in vitro in 
two groups of rats: saline-injected controls and severely shocked rats. 
After decapitation, hearts and spleens were removed from both groups of 
rats. Tissues were sliced at 4° C with a Stadie-Riggs tissue slicer to 
a thickness of 0.5 mm. Approximately 100 mg samples were placed in 
flasks containing 4.9 ml of Krebs Ringer Bicarbonate buffer. The 
samples were preincubated for 10 minutes at 37° C in a Dubnoff metabolic 
shaker while being gassed with 95% oxygen and 5% carbon dioxide. 
Norepinephrine and 3H-norepinephrine were added in a total volume of 0.1 
ml to bring the final concentration of norepinephrine to 10-7 Mand 0.1 
~Ci/ml. Tissues were then incubated for an additional O, 10, 20, or 30 
minutes. At the end of the incubation period tissues were removed from 
the incubation media, rinsed twice in cold (4° C) Krebs Ringer 
Bicarbonate buffer, frozen rapidly between tongs precooled in liquid 
nitrogen, and subsequently stored in liquid nitrogen. Samples were 
analyzed for total 3H-norepinephrine content as described above. Total 
norepinephrine retention (the amount of norepinephrine that was taken up 
and retained as unmetabolized norepinephrine) was expressed in pmol/100 
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mg tissue wet weight. The value was calculated as the quotient of the 
tissue 3H-norepinephrine content (dpm/mg tissue) and the specific 
activity of the incubation media (dpm/pmol norepinephrine). In some 
experiments an additional sample of tissues was incubated for 30 minutes 
at 37° C in the presence of 10-3 M desmethylimipramine, a potent Uptake 
inhibitor, to characterize the measured reuptake as neuronal in 
nature. A number of dose response curves were generated that 
demonstrated over 90% of the 3H retention was eliminated in both control 
and endotoxic rats by incubation of the tissues with 10-3 M 
desmethylimipramine. 
G. NorepineEhrine Turnover Measurement 
Norepinephrine turnovers were measured in hearts and spleens by 
the 3H-norepinephrine decay method (26). This technique relies on the 
neuronal uptake of norepinephrine and its rapid equilibration with 
endogenous stores. Once the tissue pool of norepinephrine has been 
labeled, 3H-norepinephrine is released along with the unlabeled 
norepinephrine. Replenishment of the pool by biosynthesis of unlabeled 
norepinephrine decreases the specific activity of norepinephrine in the 
tissue. Thus, the greater the nerve activity, the more rapidly 
3H-norepinephrine disappears from the tissue. If the total pool of 
norepinephrine remains constant, the reduction of norepinephrine 
specific activity obeys first order kinetics and rate constants of decay 
are calculated. During endotoxin shock the depletion of norepinephrine 
from peripheral organs is dose and time dependent (120). Therefore, in 
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the present experiments low dose endotoxin treatment (6.7 mg/kg or 
approximately 2 mg/300 gm rat; preliminary testing indicated a lethality 
of 5% at 24 hours) was used to minimize the tissue depletion of 
norepinephrine. 
For turnover studies, rats were housed individually as described 
above for three days prior to and at all times during the 12 hour 
experiment. Two experimental groups were used: 1) endotoxic rats (6.7 
mg/kg) and 2) saline-injected controls. Rats (321 ~ 3 gm) were 
injected intravenously with high specific activity (11 Ci/mmol) 
l-(7,8-3H)-norepinephrine (20 vCi/kg) one minute prior to injection with 
either saline or endotoxin. The rats were killed at preselected times 
by decapitation. Each time point of the turnover study represents four 
to seven animals from each experimental group. Hearts and spleens were 
rapidly removed, blotted, and frozen between brass tongs precooled in 
liquid nitrogen. The samples were subsequently stored in liquid 
nitrogen until analyzed for norepinephrine content and the specific 
activity of norepinephrine as described above. The specific activity of 
norepinephrine (dpm/ug norepinephrine) was calculated as the quotient of 
3H-norepinephrine present in the sample (dpm/gm tissue) and tissue 
norepinephrine content (»g norepinephrine/gm tissue). 
The specific activity of tissue norepinephrine was plotted 
versus time on a semi-logarithmic scale after injection of a tracer dose 
of 3H-norepinephrine. The decay of specific activity versus time obeys 
first-order kinetics (and thus describes a straight line on a 
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semi-logarithmic plot) when low doses of high specific activity 
3H-norepinephrine are injected (25). This was the case in the present 
experiments. A regression line was calculated by the method of least 
squares. Kinetic data were determined as follows (12,27,105): 
where: NE = endogenous concentration of norepinephrine in the tissue 
(ug/gm tissue vet weight); 
NE* • concentration of 3H-norepinephrine divided by NE at any 
time, t (i.e. the specific activity of norepinephrine in 
the tissue in dpm/ug norepinephrine); 
NE*. NE* at time zero (i.e. the time of tracer injection); 
0 
k • the rate constant • of NE decay in the tissue, i.e. the 
fraction of the norepinephrine pool replaced per unit 
time (hr-1); 
Tt = turnover time, i.e. the time required to synthesize the 
amount of norepinephrine stored in the tissue (hr); Tt is 
the reciprocal of the rate constant, k; 
Tr = turnover rate, i.e. the rate at which the norepinephrine 
pool is renewed per unit time (ug norepinephrine/gm 
tissue wet weight)/hr); 
* T1; 2 • time required for NE0 to decline by one half; 
Then, according to first order kinetics: 
* • dNE /dt • -k(NE ); 
integration yields: 
and, 
log NE*• log NE: - 0.434(k)(t). 
94 
The equation is now of the form: yamx+b, so 
o.434(k) • the slope, 
and 
1 NE* -og 0 - the y intercept 
* of the graph log NE versus time. 
Then by substituting T1; 2 for t and (1/2)NE* for NE: in the integrated 
form of the equation above, 
T1/2 • (0.693)/k, 
Tt • 1/k • (1.44)T1; 2 , 
and 
Tr • (NE)k. 
Although the graphs depict the specific activity plotted versus 
time on semi-logarithmic coordinates, the values of the slope and rate 
constant (k) were calculated on the basis of the logarithm of the 
specific activity to conform to the usual convention. 
H. Statistical Analysis 
Unless otherwise stated, all data were expressed as mean.:!:_ SEM. 
Statistical significance was tested by two methods except where noted. 
For comparison of two groups an independent Student's t test was used. 
The comparison of more than two groups was accomplished with an 
independent analysis of variance. Significant F tests were followed by 
the mean separation technique of a least significant difference (LSD). 
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A p value of less than 0.05 was accepted as achieving a significant 
difference. 
For norepinephrine turnover experiments, differences between the 
slopes of the regression lines were tested with a Student's t test, 
using the standard error 
norepinephrine content were 
variance. 
of sample 
tested by 
regression. Differences 
an independent analysis 
in 
of 
CHAPTER V 
RESULTS 
A. Demonstration of Norepinephrine Depletio~ durint Endotoxin Shock 
Rats were injected with saline or endotoxin (5 mg/300 gm rat) 
and sacrificed at the earlier of two times: five hours after injection 
or near death. Plasma glucose was measured from a mixed arterial/venous 
blood sample; hearts and spleens were analyzed for norepinephrine and 
epinephrine content. Table III depicts the results of these experiments 
for all endotoxic rats versus saline controls. The plasma glucose 
concentration was significantly reduced in both groups of endotoxic rats 
(p<0.01). Cardiac norepinephrine was significantly reduced (p<0.01) in 
the endotoxic group from a control value of 0.995 ~ 0.05 pg/gm (mean~ 
SEM) to 0.600 ~ 0.06 pg/gm. Similarly, splenic norepinephrine content 
was depressed in the endotoxic group: 1.214 + 0.07 ~g/gm for controls 
and 0.553 ~ 0.07 ~g/gm for endotoxic rats (p<0.01). 
Epinephrine content is reported only for cardiac samples. The 
trihydroxyindole technique limits the quantitation of epinephrine in a 
mixed norepinephrine/epinephrine sample to those epinephrine values that 
are greater than 5% of the norepinephrine content for that sample (29). 
Thus, in samples that contain relatively high amounts of norepinephrine 
(as in spleens from control rats) the epinephrine values are usually too 
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TABLE III. PLASMA GLUCOSE AND TISSUE CATECHOLAMINE CONTENT 
OF ENDOTOXIC AND CONTROL RATS 
CARDIAC NOREPINEPHRINE 
(llg/ gm) 
CARDIAC 
Plasma Glucose 
(mg/dl) 
N 
EPINEPHRINE 
(llg/ gm) 
Plasma Glucose 
(mg/dl) 
N 
SPLENIC NOREPINEPHRINE 
(µg/gm) 
Plasma Glucose 
(mg/dl) 
N 
Mean + SEM; 
Saline Control 
0.995 ~ 0.05 
90 ~ 3 
15 
0.067 + 0.02 
92 ~ 5 
5 
1.214 + 0.07 
90 ~ 3 
11 
Endotoxic 
0.600 + 0.06 * 
53 ~ 7. 
21 
0.167 ~ 0.03 * 
53 ~ 7 * 
21 
0.553 ~ 0.01 * 
47 + 7 * 
14 
* p<o-:-01 endotoxic group compared to saline control by independent 
Student's t test; 
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low to allow quantitative significance. In the myocardium, however, the 
mean epinephrine content rose from a control value of 0.087 .! 0.02 ug/gm 
to 0.187 .! 0.03 ug/gm (p<0.01). Note that due to the limitations of the 
epinephrine measurement, only 5 of 15 control rats were included in the 
calculation of epinephrine values. 
To assess the severity of shock on the catecholamine content of 
hearts and spleens, endotoxic rats were divided into mild and severe 
shock on the basis of their plasma glucose levels. Mild shock is 
denoted by a plasma glucose greater than 40 mg/dl; severe shock is 
denoted by a plasma glucose less than 40 mg/dl. The results of this 
differentiation are shown in Figures 9 and 10 for cardiac and splenic 
norepinephrine, respectively. In hearts (Figure 9), norepinephrine 
levels were significantly reduced 17% in mild shock rats (p<0.01). 
Severe shock rats demonstrated a more profound depletion in 
norepinephrine content (control: 0.985 + 0.05 ug/gm; severe shock: 0.312 
+ 0.04 ug/gm; p<0.01). This constituted a 68% reduction compared to 
control. Similar results (Figure 10) occurred in spleens from a 
different group of rats. Rats in mild shock displayed a moderate 
depletion of 36% compared to control (control: 1.21 .! 0.06 ug/gm; mild 
shock: 0.77 + 0.08 ug/gm; p<0.01). The depletion was much more 
pronounced in severely shocked rats than in the mild shock group; 
norepinephrine content was reduced 77%, from the control level of 1.21 
+ 0.06 ug/gm to 0.28 .::_ 0.03 ug/gm (p<0.01). The relationship between 
plasma glucose and norepinephrine content for all endotoxic rats is 
illustrated in Figures 11 and 12 for hearts and spleens, respectively. 
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Figure 9. 
Mean + SEM of cardiac norepinephrine content and plasma glucose 
concentration for control and endotoxic rats. Endotoxic rats were 
divided into mild and severe groups on the basis of their plasma glucose 
concentration (see text for details). Numbers of animals are indicated 
in parentheses. * p<0.01, ** p<0.05 compared to control by independent 
analysis of variance. 
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Figure 1 O. 
Mean + SEM of splenic norepinephrine content and plasma glucose 
concentration for control and endotoxic rats. Endotoxic rats were 
divided into mild and severe groups on the basis of their plasma glucose 
concentration (see text for details). Numbers of animals are indicated 
in parentheses. * p<0.01 compared to control by independent analysis of 
variance. 
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Linear regression analysis was performed to determine any correlation 
between the two parameters. For hearts (Figure 11), the equation of the 
regression line (of the form y • 111% + b) was y • o.0063x + 0.267. The 
correlation coefficient, r, was 0.73, and indicated a significant 
correlation (p<0.01) between plasma glucose and cardiac norepinephrine. 
Similar results were obtained in the spleen (Figure 12). The equation 
of the regression line was y • 0.0082x + 0.167, and demonstrated a 
significant correlation (r•0.78, p<0.01) between plasma glucose and 
splenic norepinephrine content during endotoxin shock. 
B. Characterization of the Norepinephrine Depletion Phenomenon 
1. THE SINGULAR ROLE OF HYPOGLYCEMIA ON NOREPINEPHRINE CONTENT IN HEAR? 
AND SPLEEN 
To assess the role of low plasma glucose on the norepinephrine 
depletion of endotoxicosis, one group of rats was treated with insulin 
to lower plasma glucose concentration to varying degrees. Under light 
ether anesthesia rats were injected intravenously with various amounts 
(0 to 3.5 U/kg) of regular insulin (Eli Lilly and Co.) and sacrificed 90 
minutes later. Plasma glucose was measured, and hearts and spleens were 
analyzed for catecholamine content. Figure 13 is a graph of injected 
insulin dose (U/kg) versus plasma glucose concentration (mg/dl) 90 
minutes after insulin injection. The figure illustrates the range and 
distribution of insulin doses as well as the classic relationship 
between insulin and plasma glucose levels. 
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Figure 11. 
Cardiac norepinephrine content is plotted against plasma glucose 
concentration for all endotoxic rats of Figure 9. Linear regression 
analysis indicates a significant correlation between cardiac 
norepinephrine and plasma glucose concentration (r .. 0.73, p<0.01). 
Equation (of the form y = mx + b) for the line is y .. 0.0063x + 0.267. 
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Figure 12. 
Splenic norepinephrine content is plotted against plasma glucose 
concentration for all endotoxic rats of Figure 10. Linear regression 
analysis indicates a significant correlation between splenic 
norepinephrine and plasma glucose concentration (r=0.78, p<0.01). 
Equation (of the form y = mx + b) for the line is y = 0.0082x + 0.167. 
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Figure 13. 
Graph depicts the relationship between the injected dose of 
insulin (U/kg) and the plasma glucose concentration (mg/dl) 90 minutes 
after intravenous insulin injection. 
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The results of the experiments are shown in Table IV. For each 
organ, the data are first shown for the entire shock or insulin 
hypoglycemia group. The groups are then shovn separated into mild and 
severe groups (insulin-treated rats were separated into mild and severe 
groups by the same criteria as endotoxic rats). The plasma glucose 
concentrations were comparable between shock and insulin groups. 
However during the mild phase, insulin hypoglycemia had a tendency 
toward lower plasma glucose than respective endotoxic samples (not 
statistically significant), while during the severe phase, the shock 
group demonstrated lower plasma glucose levels (p<0.01). Comparison 
between norepinephrine content for all animals in the shock and insulin 
groups demonstrated that for both hearts and spleens the norepinephrine 
content of the insulin hypoglycemic group always contained greater 
amounts of norepinephrine than the shock group (p<0.01 in both cases). 
Similar results were found when the total groups were separated into 
mild and severe groups. Cardiac norepinephrine was significantly 
reduced 12% in the mild shock group (p<0.05) and 64% in the severe shock 
group (p<0.01) compared to the respective insulin hypoglycemic groups. 
Similarly, splenic norepinephrine was significantly reduced 38% in the 
mild shock group and 75% in the severe shock group compared to the 
respective insulin hypoglycemic groups (p<0.01 in both cases). 
Closer inspection of organ norepinephrine content in the insulin 
hypoglycemic group revealed that no significant reduction from saline 
controls occurred. In the spleen, norepinephrine content in saline 
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TABLE IV. COMPARISON BETWEEN ENDOTOXIN- AND INSULIN-INDUCED HYPOGLYCEMIA 
ON HEART AND SPLEEN NOREPINEPHRINE CONTENT 
HEART 
All Shock 
All Insulin 
Hypoglycemia 
Mild Shock 
Mild Insulin 
Hypoglycemia 
Severe Shock 
Severe Insulin 
Hypoglycemia 
SPLEEN 
All Shock 
All Insulin 
Hypoglycemia 
Mild Shock 
Mild Insulin 
Hypoglycemia 
Severe Shock 
Severe Insulin 
Hypoglycemia 
N 
21 
41 
12 
27 
9 
14 
20 
33 
11 
24 
9 
9 
Tissue Plasma 
Norepinephrine Glucose 
(11~/gm) (ms/dl) 
0.600 + 0.06 53 .:!:. 7 
• 
0.905 .:!:. 0.03 52 .:!:. 4 
0.816 .:!:. 0.03 75 .:!:. 7 
.. 
0.924 .:!:. 0.03 63 .:!:. 3 
0.312 .:!:. 0.04 24 ~ 2 
* * 
0.868 .:!:. 0.05 33 .:!:. 1 
0.553 .:!:. 0.07 47 ~ 7 
• 
1 .225 ~ 0.07 59 ~ 4 
0.772 + o.os 70 + 6 
• 
1.254 ~ 0.09 69 ~ 3 
0.284 + 0.04 18 + 2 
* * 
1.149~0.14 31 + 2 
• p<0.01, ** p<0.05 for shock versus insulin hypoglycemia group by 
independent Student's t test; 
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controls was 1.214 ~ 0.07 ug/gm. This was not significantly different 
from either the mild insulin hypoglycemic group (1.254 ~ 0.09 ug/gm) or 
the severe insulin hypoglycemic group (1.149 ~ 0.14 ug/gm). In the 
heart, norepinephrine content of saline controls was 0.985 ~ 0.05 ug/gm. 
There was no statistical reduction in either the mild (0.924 ~ 0.03 
ug/gm) or severe insulin hypoglycemic group (0.868 ~ 0.05 ug/gm). 
Figures 14 and 15 illustrate the relationship between plasma glucose and 
norepinephrine content for hearts and spleens of all insulin 
hypoglycemic rats. Linear regression analysis was performed by the 
method of least squares. The equation of the regression line (of the 
form y "' mx + b) for cardiac norepinephrine versus plasma glucose 
(Figure 14) was y • o.0014x + o.s33. The correlation coefficient, r 
(0.15), was not significantly different from 0 (p>0.05); no correlation 
between cardiac norepinephrine content and plasma glucose occurred. 
Similar results were obtained in the spleen (Figure 15). The equation 
of the regression line was y • -0.0002x + 1.23s. No correlation between 
splenic norepinephrine and plasma glucose was evident (rs-0.01, p>o.05). 
Cardiac epinephrine was also quantitated in the insulin 
hypoglycemic rats. Epinephrine content of saline-injected controls was 
0.087 + 0.02 ug/gm (n=5). Mild insulin hypoglycemia significantly 
raised cardiac epinephrine levels 10% (0.096 ~ 0.01 ug/gm; n=24); severe 
insulin hypoglycemia resulted in a marked 115% increase in cardiac 
epinephrine levels (0.189 + 0.04 µg/gm). Figure 16 depicts the 
relationship between plasma glucose and cardiac epinephrine for all 
insulin hypoglycemic rats. The equation of the regression line was y = 
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Figure 14. 
Graph depicts cardiac norepinephrine content versus plasma 
glucose concentration for all rats treated with insulin. Linear 
regression analysis indicates no correlation between norepinephrine 
content and plasma glucose concentration (r= 0.15, p>0.05). Equation of 
the line (of the form y = mx + b) is y = o.0014x + o.s33. 
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Figure 15. 
Graph depicts splenic norepinephrine content versus plasma 
glucose concentration for all rats treated with insulin. Linear 
regression analysis indicates no correlation between norepinephrine 
content and plasma glucose concentration (r= -0.01, p>0.05). Equation 
of the line (of the form y = mx + b) is y s -0.0002x + 1.23s. 
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Figure 16. 
Graph depicts cardiac epinephrine content versus plasma glucose 
concentration for all rats treated with insulin. Linear regression 
analysis indicates a significant negative correlation between 
norepinephrine content and plasma glucose concentration (r= -0.66, 
p<0.01). Equation of the line (of the form y = mx + b) is y = -0.0019x 
+ 0.213. 
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-0.0019x + 0.213. A significant negative correlation (r•-0.656; p<0.01) 
existed between cardiac epinephrine and plasma glucose for insulin 
hypoglycemic rats. 
2. THE ROLE OF NEURAL MEDIATION IN THE NOREPINEPHRINE DEPLETION OF 
ENDOTOXIC SHOCK 
To test the hypothesis that the norepinephrine depletion was 
dependent on neural activity, rats were injected intravenously with the 
ganglionic blocker, chlorisondamine (5 mg/kg), one hour after endotoxin 
injection (5 mg/300 gm rat). Preliminary experiments showed that 
pretreatment or cotreatment of chlorisondamine sensitized rats to 
endotoxin lethality (rats usually died while still under ether 
anesthesia or within five to ten minutes). Therefore, ganglionic 
blockade was administered one hour after endotoxin (post-hypotensive 
phase). This regimen was tolerated better by rats, and the time to 
death of the ganglionic blockade group (176 + 21 min) was not 
significantly different 
blockade (169 ~ 35 min). 
than the endotoxic rats without ganglionic 
cardiac norepinephrine for 
Figure 17 illustrates the plasma glucose and 
these experiments. An additional group of 
endotoxic rats was sacrificed at one hour after endotoxin to act as a 
control for rats with ganglionic blockade. Ganglionic blockade 
effectively eliminated any norepinephrine depletion after one hour 
post-endotoxin (0.832 + 0.05 ~g/gm for one hour of endotoxin; 0.748 + 
0.04 ~g/gm for endotoxin plus ganglionic blockade). Plasma glucose 
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Figure 17. 
Illustration of cardiac norepinephrine content and plasma 
glucose concentration in control, endotoxic, and endotoxic rats 
pretreated with chlorisondamine (5 mg/kg). Within the bars the mean + 
SEM are shown. Number of rats is illustrated in parentheses. ** p<0.01 
versus adjoining bar by independent analysis of variance. 
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levels in the_ganglionic blockade group (30 ..:!:. 6 mg/dl) reached levels as 
low as the severe shock group (24 ..:!:. 2 mg/dl). 
3. EFFECT OF ADRENERGIC MANIPULATION ON ENDOTOXIN-INDUCED LETHALITY AND 
NOREPINEPHRINE DEPLETION 
Adrenergic blockade and sympathectomy have been shown to have 
variable effects on the pathogenesis of endotoxin shock. To further 
investigate this area, rats were treated with either postsynaptic 
adrenergic blocking agents or chemically sympathectomized to prevent 
presynaptic release of norepinephrine. In the first set of experiments 
rats were treated with either an alpha adrenergic blocking agent 
(phentolamine) or beta adrenergic blocking agent (propranolol) and then 
subjected to the present shock model. In awake rats, phentolamine (3 
mg/kg) or propranolol (4 mg/kg) was injected intraperitoneally 15 
minutes before endotoxin was injected intravenously (5 mg/300 gm rat) 
under light ether anesthesia. A control group of rats was injected with 
only endotoxin. Rats were killed 5 hours later or near death. Results 
of these experiments are shown in Table v. All phentolamine plus 
endotoxin rats lived for the maximum five hours (300 ..:!:. 0 min) of the 
experiment. This was significantly longer than either the endotoxin 
alone group (277 ..:!:. 12 min) or the propranolol plus endotoxin group (18 
..:!:. 1 min). Propranolol significantly decreased time to death compared to 
the endotoxin alone group. Although plasma glucose was no different 
between endotoxin and propranolol plus endotoxin in this series, 
phentolamine plus endotoxin rats had significantly higher glucose levels 
123 
TABLE V. EFFECTS OF PROPRANOLOL OR PHENTOLAMINE PRETREATMENT 
ON ENDOTOXIN SHOCK IN THE RAT 
Plasma Glucose 
(mg/dl) 
Time to Death 
(minutes) 
Cardiac 
Norepinephrine 
(µg/gm) 
Splenic 
Norepinephrine 
(v.g/ gm) 
Endo toxin 
Alone 
51 + 14 
(8) 
277 + 12 
(8) 
0.617 + 0.10 
(8) 
0.520 + 0.11 
Cf) 
Propranolol 
Plus Endotoxin 
43 + 5 
Cf) 
• 
18 + 1 
(12) 
0.761 + 0.05 
(7) 
0.812 + 0.07 
Cf) 
Phentolamine 
Plus Endo toxin 
• II 
78 + 5 
(8) 
• II 
300 + 0 
( 1T) 
• 
0.853 + 0.07 (8) 
* 
0.887 + 0.13 
(7) 
Values are mean + SEM. The number of samples is in parentheses below 
each value. 
* p<0.05 versus endotoxin alone, 
II p<0.05 versus propranolol plus endotoxin, 
by independent analysis of variance. 
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than either of the other eroups. Borepinephrine content in both the 
heart and spleen was statistically ereater in the phentolamine plus 
endotoxin eroup than in the endotoxin alone group. However, 
norepinephrine content of hearts and spleens in propranolol-treated rats 
was intermediate and no different than in either of the other two 
groups. 
The effects of blunted release of norepinephrine was next 
investigated by chemically sympathectomizing rats before endotoxin 
challenge. Animals sympathectomized with 6-hydroxydopamine contain 
minimal norepinephrine in peripheral sympathetic nerve endings, and 
higher than normal catecholamine levels in adrenal medullary tissue 
(norepinephrine and epinephrine). Because norepinephrine has relatively 
more alpha adrenergic effect and epinephrine has more beta adrenergic 
effect, chemical sympathectomy would accentuate beta adrenergic activity 
and minimize alpha adrenergic activity. In light of the phentolamine 
and propranolol 
decrease alpha 
experiments, 6-hydroxydopamine is hypothesized to 
adrenergic stimulation of sympathetically innervated 
tissues, leave adrenal medullary secretion of catecholamines intact, and 
significantly protect against endotoxic lethality. Under light ether 
anesthesia, rats 
me/kg) and then 
6-hydroxydopamine 
were injected intravenously with phentolamine (10 
either saline or 6-hydroxydopamine (80 mg/kg). 
was weighed out as the free base of the amine 
complexed with hydrobromide and dissolved in saline containing 1% 
ascorbate. Phentolamine was administered to minimize the blood pressure 
increase that occurred after 6-hydroxydopamine injection and subsequent 
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norepinephrine liberation. Preliminary experiments indicated that this 
regimen of treatment with 6-hydroxydopamine reduced cardiac 
norepinephrine levels by 88% and splenic norepinephrine levels by 93%. 
Endotoxin was administered 48 hours later. The lethality data is 
illustrated in Table VI. Chemical sympathectomy significantly reduced 
the lethality associated with endotoxin injection. The protective 
effect of sympathectomy was first demonstrated at 6 hours after 
endotoxin and was present for the duration of the study up to 24 hours 
post endotoxin. 
c. Norepinephrine Reuptake 
1. IN VIVO 3H-NOREPINEPHRINE UPTAKE IN ENDOTOXIC SHOCK 
The results of in vivo assessment of the reuptake process in 
endotoxicosis are presented in Tables VII and VIII for hearts and 
spleens, respectively. Four groups of rats were evaluated: 1) 
saline-injected controls, 2) mild, and 3) severe shock rats, and 4) a 
separate group of rats pretreated with the neuronal reuptake blocker of 
norepinephrine, desmethylimipramine (DMI). The last group was employed 
to evaluate the singular effect of depressed reuptake in this 
experimental paradigm. 
In the myocardium (Table VII) DMI had no effect on the level of 
endogenous norepinephrine, but DMI reduced the amount of 
3H-norepinephrine accumulated in the tissue by 95% ten minutes after 
TABLE VI. EFFECT OF SYMPATHECTOMY WITH 6-HYDROXYDOPAMINE (6-0HDA) 
ON ENDOTOXIN-INDUCED LETHALITY 
Hours After % Lethality % Lethality 
Endo toxin Control 6-0HDA 
0 0 ( 0/27)# 0 ( 0/27) 
0 ( 0/27) 0 ( 0/27) 
2 7 ( 2/27) 0 ( 0/27) 
3 7 ( 2/27) 0 ( 0/27) 
4 19 ( 5/27) 7 ( 2/27) 
5 22 ( 6/27) 7 ( 2/27) 
6 26 ( 7/27) * 7 ( 2/27) 
7 26 ( 7/27) * 7 ( 2/27) 
8 30 ( 8/27) * 11 ( 3/27) 
9 52 (14/27) ** 15 ( 4/27) 
10 56 (15/27) ** 15 ( 4/27) 
11 56 (15/27) ** 19 ( 5/27) 
12 56 (15/27) ** 19 ( 5/27) 
24 56 (15/27) ** 26 ( 7/27) 
* p<0.05, ** p<0.01 compared to control by Chi Square; 
#numbers in parentheses indicate number of deaths I total initial 
number of animals; 
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Rats were treated with 6-0HDA 48 hours before endotoxin 
challenge. There were a total number of 27 rats in each group ~t time 0 
hours. 
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TABLE VII. IN VIVO 3H-NOREPINEPHRINE (3H-NE) UPTAKE IN RAT MYOCARDIUM 
Plasma 
Glucose Norepinephrine 3H-NE 
Group N (mg/dl) (11g/gm) (dpm/gm) 
91 o.eo 11838 
Control 7 
,:3 ,:0.05 ,:845 
Desmethyl- 87 0.72 ** 650 
7 
imipramine +7 +0.04 +110 
Mild 95 ** o.66 13414 
15 
Shock ,:5 +0.01 ,:740 
Severe ** 23 ** 0.48 17783 
7 
Shock ,:3 +0.06 ,:2904 
Mean + SEM 
** p<0.05 compared to control by independent analysis of variance; 
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TABLE VIII. IN VIVO 3H-NOREPINEPHRINE (3H-NE) UPTAKE IN RAT SPLEEN 
Plasma 
Glucose Norepinephrine 3H-NE 
Group N (mg/dl) ()lg/gm) (dpm/gm) 
91 0.86 2309 
Control 7 
_:3 +0.02 _:224 
Desmethyl- 87 0.94 .. 366 
7 
imipramine +7 _:0.09 +48 
Mild 95 ** 0.50 ** 1522 
15 
Shock _:238 
Severe .. 23 .. 0.27 .. 270 
7 
Shock +0.06 
Mean + SEM 
** p<0.05 compared to control by independent analysis of variance; 
intravenous injection of the labeled bioamine. 
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In both mild and 
severely shocked endotoxic rats, 3H-norepinephrine uptake was not 
changed from control. However, note that the relative depletion of 
endogenous norepinephrine is similar to the group of rats in which the 
depletion was demonstrated (Figure 9). 
In the spleen (Table VIII), DMI pretreatment again had no effect 
on endogenous norepinephrine content, but it depressed the accumulation 
of injected 3H-norepinephrine by 84%. Mild and severe shock produced 
depression of the endogenous norepinephrine content of the spleen. 
However, unlike the myocardium, during both mild and severe 
endotoxicosis, spleen uptake of circulating 3H-norepinephrine was 
depressed. In mild shock, 3H-norepinephrine content in spleens was 
reduced from a control value of 2309 ~ 224 dpm/gm to 1522 ~ 238 dpm/gm 
(34% reduction). Severe shock rats demonstrated an 88% decrease in 
3H-norepinephrine accumulation to 270 ~ 69 dpm/gm. 
2. IN VITRO 3H-NOREPINEPHRINE UPTAKE 
Because in vivo experiments suggested that reuptake depression 
would be most prominent in severe shock rats, in vitro analysis of 
norepinephrine uptake was performed in control and severe shock groups. 
The results of these experiments for heart and spleen slices are shown 
in Figures 18 through 21. 
or 30 minutes at 37° C 
norepinephrine. Total 
Tissue slices were incubated for 0, 10, 20, 
in the presence of labeled and unlabeled 
3H and 3H-norepinephrine were measured. 
Figure 18. 
Total 3H retention in myocardial slices of control and severely 
shocked rats incubated for the indicated time with 3H-norepinephrine. 
Each bar represents the mean + SEM for 6 preparations, each from a 
different rat. NS represents no significant difference for severe shock 
group versus control. 
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Figure 19. 
Total norepinephrine retention for myocardial slice preparations 
of Figure 18 calculated from the 3H-norepinephrine content of the tissue 
and the specific activity of the incubation media. Each bar represents 
the mean + SEM for 6 preparations, each from a different rat. NS 
represents no significant difference for severe shock group versus 
control. 
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Figure 20. 
Total 3H retention in splenic slices of control and severely 
shocked rats incubated for the indicated time with 3H-norepinephrine. 
Each bar represents the mean + SEM for 5 preparations, each from a 
different rat. NS represents no significant difference for severe shock 
group versus control. 
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Figure 21. 
Total norepinephrine retention for splenic slice preparations of 
Figure 20 calculated from the 3H-norepinephrine content of the tissue 
and the specific activity of the incubation media. Each bar represents 
the mean_:!:. SEM for 5 preparations, each from a different rat. 
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Norepinephrine retention (pmol/100 mg) was calculated as the quotient of 
the tissue 'H-norepinephrine content (dpm/mg tissue) and the specific 
activity of the incubation media (dpm/pmol norepinephrine). In 
myocardial slices (Figure 18) at all times of incubation at 37° C there 
were no differences in total 3H retention between control and severe 
shock 
both 
21), 
rats. Similarly, total norepinephrine retention was the same in 
groups of heart slices (Figure 19). In the spleen (Figures 20 and 
total 3H and total norepinephrine retention were severely reduced 
in tissue slices of severely shocked rats at all times of incubation at 
37° C. The reduction was on the order of 50% at all times tested. The 
results of in vitro analyses are thus consistent with in vivo 
experiments, i.e. depressed reuptake of norepinephrine occurs in 
spleens, but not in hearts of endotoxic rats. 
Because neuronal reuptake is temperature sensitive, incubations 
were also carried out for 30 minutes at 4° C. Cold incubation (Figures 
20 and 21) effectively abolished all norepinephrine retention. 
Preliminary experiments with DMI in the incubation media indicated 
reuptake depression equal to cold incubation. Thus, the measured 
norepinephrine retention is dependent on neuronal reuptake and not 
non-neuronal reuptake or non-specific binding. 
One profound consequence of shock is splanchnic congestion and 
accumulation of cellular debris in the spleen. Increase in tissue wet 
weight during shock would thus lower the measured norepinephrine 
accumulation values. To evaluate this possibility, both spleens and 
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hearts were remoyed from control and severely shocked animals, weighed, 
and then dried to constant weight. The results are shown in Table IX. 
There were no differences in wet weight, dry weight, or dry to wet 
weight ratios in hearts from control and shock animals. In the spleen, 
wet weight increased from 0.851 .:!: 0.038 gm to 1.013 .:!: 0.082 gm and dry 
weight increased from 0.195 + 0.009 gm to 0.239 .:!: 0.023 gm in the 
endotoxic state. Both of these increases approached but did not reach 
significance (p•0.10 for both vet and dry weight differences). The 
splenic dry to wet weight ratio also did not change in the shock state 
(control: 0.229 .:!: 0.001; severe shock: 0.234 .:!: 0.004; p•0.23). 
Although the weight changes in the spleen were not significant, 
the difference represents a 19% increase in wet weight and a 22% 
increase in dry weight in the severe shock rats. The parallel tendency 
for both spleen wet and dry weight to increase with no change in the dry 
to wet weight ratio suggests an increase in total cellular mass (most 
likely a congestion with red blood cells or cellular debris) of the 
spleen rather than a pure edema. The number of reuptake sites per unit 
of tissue wet weight will decrease if the spleen is infiltrated by 
cellular debris. Therefore, the measured amount of norepinephrine 
retention per 100 mg of tissue would be expected to decrease (in this 
case by 19%) simply due to an increase in cellular mass of the spleen. 
Therefore, the norepinephrine data for the spleen was corrected for 
changes in spleen vet weight of the endotoxic group (Figure 22). Even 
using this conservative modification, spleen slices from endotoxic rats 
retained significantly less norepinephrine than those from controls. 
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TABLE IX: MYOCARDIUM AND SPLEEN WEIGHTS IN CONTROL AND ENDOTOXIC RATS 
CONTROL MILD SHOCK SEVERE SHOCK 
N 8 8 7 
Plasma Glucose 110 • 82 • 35 
(mg/dl) _:4 _:5 _:5 
MYOCARDIUM 
Wet Weight 1 .491 1.485 1.429 
(gm) 
_:0.035 _:0.036 +0.088 
Dry Weight 0.351 0.347 0.331 
(gm) +0.010 +0.008 +0.020 
Dry/Wet 0.236 0.234 0.234 
Weight Ratio _:0.003 +0.002 _:0.003 
SPLEEN 
Wet Weight 0.951 ** 1.154 1 .013 
(gm) ;!;_0.038 _:0.091 +0.082 
Dry Weight 0.195 ** 0.261 0.239 
(gm) ;!;_0.009 ;!;_0.023 ;!;_0.023 
Dry/Wet 0.229 0.234 0.234 
Weight Ratio +0.001 ;!;_0.003 +0.004 
Mean .:!:._ SEM; 
* p<0.01 vs control, 
** p<0.05 vs control by independent analysis of variance; 
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Figure 22. 
Total norepinephrine retention for spleen slice data of Figure 
21 corrected for a 19% wet weight increase in spleens from severely 
shocked rats. Each bar represents the mean .:. SEM for 5 preparations, 
each from a different rat. NS represents no significant difference for 
severe shock group versus control. 
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3· INRACELLULAR DEGRADATION OF 3H-NOREPINEPHRINE AFTER UPTAKE 
Because the neuronal reuptake process (Uptake 1) is energy 
dependent and is compromised in the spleen, it is reasonable to suspect 
other energy sensitive processes to be affected in the spleen. After 
reuptake of norepinephrine, repackaging of the catecholamine into 
vesicles requires energy. One consequence of decreased rate of 
repackaging is an increase in intraneuronal degradation by the soluble 
enzyme, monoamine oxidase. The ratio of 3H-norepinephrine to 3H 
recovered by a tissue is indicative of the amount of norepinephrine 
taken up, repackaged, and conserved in its unmetabolized form. Figure 
23 depicts the results of these calculations in spleen slices. At all 
times of incubation, tissues from shocked rats demonstrated 
significantly less 3H retained in the form of 3H-norepinephrine. 
Therefore, these data are consistent with the hypothesis that in 
endotoxic rats, norepinephrine degradation is accelerated in the nerve 
terminals of peripheral tissues. 
D. Measurement of Sympathetic Activity in Hearts and Spleens of Control 
and Endotoxic Rats 
1. TISSUE NOREPINEPHRINE LEVELS IN CONTROL AND ENDOTOXIC RATS 
Kinetic 
3H-norepinephrine 
analysis of norepinephrine 
decay method is dependent on 
turnover by the 
steady state tissue 
144 
Per cent 
unmetabolized form 
severely shocked 
Figure 23. 
of radioactive label (3H) recovered in its 
(3H-norepinephrine) in spleen slices of control and 
rats coincubated with 3H-norepinephrine for the 
indicated time. Each bar represents the mean + SEM for 5 preparations, 
each from a different rat. 
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levels of the bioamine throughout the 12 hour experiment (12,27). Table 
X illustrates the norepinephrine content in hearts and spleens of 
saline-injected control and endotoxic rats. Groups of rats were 
sacrificed at each of the indicated times after 3H-norepinephrine 
injection. An independent analysis of variance was performed on each of 
the four groups of values. No statistical differences (p>0.10) in 
norepinephrine content exist between sampling times for any single organ 
experimental group. Thus, the reduced dose of endotoxin (2 mg/rat; 
5-7-6.7 mg/kg) used in this series of experiments was sufficient to 
prevent the norepinephrine depletion of endotoxicosis. However, it is 
important to note that the stress of endotoxicosis in these particular 
experiments (LD 5%) is much less than in the general shock model (60 -
70%) used in the rest of the experiments. 
2. NOREPINEPHRINE TURNOVER IN ENDOTOXICOSIS 
Figure 24 illustrates the decay of myocardial 3H-norepinephrine 
specific activity in control and endotoxic rats. Norepinephrine 
specific activity (dpm/ug norepinephrine) is plotted on a logarithmic 
scale. 
hearts 
The slope of the specific activity versus time decay line for 
from endotoxic rats (-0.047) was significantly increased 
(p<0.001) compared to the slope calculated for saline-injected control 
rats (-0.006). Figure 25 depicts specific activity decay lines for 
spleens of control and endotoxic rats. The slope of the line for the 
endotoxic group (-0.049) was markedly increased (p<0.001) over the 
control slope (-0.015). The constant level of endogenous norepinephrine 
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TABLE X. TISSUE LEVELS OF NOREPINEPHRINE IN HEARTS 
AND SPLEENS OF CONTROL AND ENDOTOXIC RATS 
CONTROL ENDOTOXIN 
NE HOURS AFTER NE 
n µg/g 3H-NE INJECTION n Jlg/g 
HEART 
5 0.70.: 0.04 0.17 7 o.66 .: 0.03 
6 0.72 + 0.06 3.00 7 0.69 .: 0.04 
6 0.69.: 0.04 6.00 6 0.68 + 0.06 
6 0.67 + 0.04 9.00 6 0.72.: 0.05 
6 o.66 .: 0.03 12.00 4 0.69 .: 0.04 
SPLEEN 
5 0.96 .: 0.05 1.00 4 0.97 .: 0.10 
7 1 .01 + 0.11 3.00 6 0.76 + 0.06 
7 0.90.: 0.06 6.00 5 o. 96 .: 0.07 
6 0.93 .: 0.08 9.00 6 0.89 .: 0.09 
3 0.76 + o.os 12.00 4 o. 78 .: 0.01 
Mean + SEM; There are no statistical differences in norepinephrine 
content at different times after injection within any single group 
(independent analysis of variance). 
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Figure 24. 
Decay of myocardial 3H-norepinephrine (3H-NE) specific activity 
in control and endotoxic rats. Rats were injected with 3H-NE one minute 
before injection of either saline or endotoxin. Each point represents 4 
to 7 rats. Slope of the decay line for endotoxic rats is significantly 
steeper than control (p<0.001). 
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Figure 25. 
Decay of splenic 3H-norepinephrine (3H-NE) specific activity in 
control and endotoxic rats. Rats were injected with 3H-NE one minute 
before injection of either saline or endotoxin. Each point represents 4 
to 7 rats. Slope of the decay line for endotoxic rats is significantly 
steeper than control (p<0.001). 
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and increased rate or 3H-norepinephrine disappearance from tissues of 
endotoxic rats indicate increased turnover or norepinephrine in the 
endotoxic state. 
The kinetic turnover data for hearts and spleens is summarized 
in Table XI. In hearts the mean norepinephrine content for all samples 
comprising a single decay curve was unchanged in the endotoxic group 
compared to control. Rate constants were calculated from the slopes and 
application or first order kinetics. The rate of cardiac norepinephrine 
turnover (the product of the rate constant and the endogenous 
norepinephrine content) increased more than 700% in the endotoxic group 
(0.075 µgxgm- 1xhr-1) compared to controls (0.009 µgxgm- 1xhr-1). Similar 
results occurred in the spleen. Endogenous norepinephrine content of 
all endotoxic spleens (0.87 + 0.04 pg/gm) was not significantly 
different (p=0.24) than control spleens (0.93 _: 0.04 µg/gm). Endotoxin 
treatment more than tripled the rate constant of decay from 0.035 hr-1 
in the control state to 0.114 hr-1• Thus, the turnover rate of 
norepinephrine in the spleen increased 200% in the endotoxic state 
(control: 0.033 µgxgm- 1xhr-1; endotoxin: 0.099 ~gxgm- 1 xhr- 1 ). 
3. EFFECT OF DESMETHYLIMIPRAMINE ON NOREPINEPHRINE TURNOVER 
Increased norepinephrine turnover rates in endotoxicosis 
indicate increased sympathetic tone. However, the experiments just 
reported demonstrated that spleens but not hearts from endotoxic rats 
displayed depressed norepinephrine reuptake when measured in both in 
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TABLE XI. NOREPINEPHRINE (NE) TURNOVER IN HEARTS AND SPLEENS 
OF CONTROL AND ENDOTOXIC RATS 
NE RATE CONSTANT TURNOVER RATE 
TREATMENT n µg/g SLOPE hr-1 ug/(gxhr) 
HEART 
Control 29 0.69 -0.006 0.013 0.009 
+0.02 +0.004 
Endo toxin 30 0.69 -0.047* 0.108 0.075 
+0.02 +0.006 
SPLEEN 
Control 28 0.93 -0.015 0.035 0.033 
+0.04 +0.008 
Endotoxin 25 0.87 -0.049* 0.114 0.099 
+0.04 +0.007 
Mean + SEM; 
* p<o-:-001 compared to control using the standard error of the sample 
regression. 
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vivo and in vitro situations. It is possible that the depressed eplenic 
norepinephrine reuptake of endotoxic rats may contribute to increased 
rate of transmitter loss from the terminal (both labeled and unlabeled) 
and be measured as increased turnover rate. Therefore, this hypothesis 
was tested by measuring norepinephrine turnovers in control rats 
pretreated with the neuronal norepinephrine reuptake inhibitor, DMI. 
Turnovers in both hearts and spleens were examined to determine if 
Uptake 1 had similar effects on sympathetic activity in both organs. 
Table XII illustrates the norepinephrine content in hearts and 
spleens of DMI-treated rats. The critical organ for turnover 
measurement is the spleen, since reuptake has been shown to be depressed 
in endotoxic spleens. At each time point splenic norepinephrine content 
was found to not be statistically different than any other time point. 
The same holds true for myocardial norepinephrine content. The control 
group of rats is the same as in the endotoxic turnover experiments. The 
cardiac and splenic norepinephrine content for the control rats is 
depicted in Table X. 
The specific activity decay lines for hearts and spleens of 
control and DMI-treated rats are depicted in Figures 26 and 27, 
respectively. Although the initial specific activity is not the same, 
the slopes for specific activity decay are not statistically different 
from one another in hearts of control (-0.006) and DMI-treated (-0.004) 
rats (p>0.015; Figure 26). Figure 27 illustrates that the slop~s of the 
splenic specific activity decay lines were the same (0.015 hr-1) for 
HEART 
SPLEEN 
TABLE XII. TISSUE LEVELS OF NOREPINEPHRINE (NE) IN HEARTS 
AND SPLEENS OF DESMETHYLIMIPRAMINE-TREATED RATS 
NE 
JJ.g/gm 
0.83 ~ .05 
0.73 ~ .06 
0.77 ~ .05 
0.72 + .05 
0.70 ~ .08 
0.85 ~ .10 
0.78 + .04 
0.75 ~ .09 
0.72 + .05 
0.81 + .08 
HOURS AFTER 
3H-NE INJECTION 
1.0 
6.0 
9.0 
12.0 
1.0 
3.0 
6.0 
9.0 
12.0 
n 
6 
6 
6 
6 
5 
4 
5 
6 
6 
5 
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~ean ~ SEM; Rats were injected with desmethylimipramine 10 minutes after 
H-NE injection. There are no statistical differences in norepinephrine 
content at different times after injection within any single group 
(independent analysis of variance). 
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Figure 26. 
Decay of myocardial 3H-norepinephrine (3H-NE) specific activity 
in control and desmethylimipramine-treated rats. Rats were injected 
with 3H-NE ten minutes before injection of desmethylimipramine. Each 
point represents 4 to 7 rats. Slope of the decay line for 
desmethylimipramine-treated rats is no different from control (p>0.015). 
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Figure 27. 
Decay of splenic 3H-norepinephrine (3H-NE) specific activity in 
control and desmethylimipramine-treated rats. Rats were injected with 
3H-NE ten minutes before injection of desmethylimipramine. Each point 
represents 4 to 7 rats. Slope of the decay line for 
desmethylimipramine-treated rats is no different from control (p>0.50). 
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both control and DMI-treated rats. Although the specific activity at O 
hours after 'H-norepinephrine was greater in the control sroup, the 
fractional loss of tracer from both groups was exactly the same. 
Table XIII summarizes the turnover data for control versus 
DMI-treated rats. In hearts, DMI pretreatment increased the endogenous 
level of norepinephrine. However, the rate constant of decay in hearts 
of DMI-treated rats was reduced compared to control. The turnover rates 
in both groups of rats were similar (0.009 µg/(gxhr) in controls, 0.006 
~g/(gxhr) for DMI treatment) and extremely lower than the turnover rate 
for endotoxic rats (0.075 µg/(gxhr). In spleens, DMI treatment reduced 
endogenous levels of norepinephrine slightly, but significantly. The 
fraction of norepinephrine turned over per hour was the same in both 
groups. Therefore, the 
(0.028 
splenic turnover rate of DMI-treated rats was 
~gxgm- 1 xhr-1) than in controls (0.033 slightly lower 
pgxgm-1xhr-1). Again, as in the heart, note that turnovers in spleens 
of control and DMI-treated rats were dramatically lower than in spleens 
of endotoxic rats (0.099 pg/(gxhr)). 
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TABLE XIII. NOREPINEPHRINE (NE) TURNOVER IN HEARTS AND SPLEENS 
OF CONTROL AND DESMETHYLIMIPRAMINE-TREATED RATS 
NE RATE CONSTANT TURNOVER RATE 
TREATMENT n ~ SLOPE hr-1 ;ig/(gxhr) 
HEART 
Control 29 0.69 -0.006 0.013 0.009 
+0.02 +0.004 
Desmethyl- 29 0.75* -0.004* 0.008 0.006 
imipramine ~0.03 ~0.003 
SPLEEN 
Control 28 0.93 -0.015 0.035 0.033 
+0.04 +0.008 
Desmethyl- 26 0.78* -0.015 0.036 0.028 
imipramine ~0.03 ~0.029 
Mean + SEM; 
* p<o":-001 compared to control using the standard error of the sample 
regression. 
The 
sympathetic 
CHAPTER VI 
DISCUSSION 
present experiments 
dysfunction during 
have focused on 
endotoxin shock: 
one aspect 
depletion 
of 
of 
norepinephrine from sympathetic nerve terminals. These studies can be 
categorized into four areas: 1) demonstration of the phenomenon, 2) 
characterization of the depletion, 3) assessment of norepinephrine 
reuptake, and 4) measurement of sympathetic activity during endotoxin 
shock. Each of these areas will be discussed separately. 
A. Demonstration of Norepinephrine DeEletion during Endotoxin Shock 
Fundamental to any series of experiments is an appropriate, 
reproducible model. In the present studies an endotoxic rat model was 
employed: intravenous injection of Salmonella enteritidis endotoxin at a 
dose (14 to 17 mg/kg) to generate a 60%-80% lethality. The albino rat 
has been widely used in endotoxic studies, primarily for metabolic, 
immune, and in vitro preparation experiments. The inbred genetic line 
of the laboratory rat minimizes animal to animal variations, and the 
size and cost per animal facilitates experimental repetition. Larger 
animal models, such as the dog or primate, are better suited for 
hemodynamic and cardiovascular experimentation - the so-called "pump and 
pipe" investigations. The area of present interest, norepinephrine 
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depletion from peripheral tissues, is particularly well-suited to a 
small animal model such as the rat. The rat is large enough to obtain 
adequately-sized tissues for analysis, and small enough to be 
economically feasible to generate an adequate number of samples. The 
terminal nature of the experiments and the sampling technique enable the 
studies to be performed in the absence of anesthesia. Previous 
endotoxic research using rats has generated a solid data base of 
information with respect to many metabolic, immunological, and even 
hemodynamic responses to endotoxin administration. Finally, although 
endotoxin-induced norepinephrine 
demonstrated in the rat (120), 
depletion has been previously 
the characteristics and mechanisms 
involved have not been adequately defined. Thus, the rat is an 
appropriate model for study of norepinephrine depletion and sympathetic 
dysfunction during endotoxicosis. 
Initial experiments demonstrated norepinephrine depletion from 
hearts and spleens of endotoxic rats (Table III). The depletion was 
shown to be correlated with the terminal plasma glucose of the rats 
(Figures 9-12). This finding was consistent throughout the course of 
all the experiments. Previous work has shown that initially plasma 
glucose rises and then falls to hypoglycemic levels during endotoxicosis 
(45). Using this criteria, the norepinephrine depletion was shown to be 
associated with the severity of hypoglycemia, and hence the severity of 
the shock state. These results are consistent with the study of 
Pohorecky et al. (120) who observed that norepinephrine depletion from 
peripheral tissues in the endotoxic rat was a dose- and time-dependent 
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phenomenon. According to the protocol, rats were sacrificed one to five 
hours after endotoxin administration. Because animals progress through 
the shock state at different rates, the present model of sacrificing 
animals at 5 hours after endotoxin or near death sampled animals at all 
stages of shock. A qualitative observation was that animals surviving 
to the 5 hour limit were found to be of the mild shock group (plasma 
glucose greater than 40 mg/dl). Rats that neared death before the 5 
hour period (and were sacrificed at that time) were usually of the 
severe shock group (plasma glucose less than 40 mg/dl). On this basis, 
the norepinephrine depletion could be considered to be inversely related 
to the time of endotoxicosis, and hence contrary to the results of the 
Pohorecky study. 
sampling 
protocol 
procedure 
allowed 
However, the discrepancy is resolved because the 
was different in the two studies. The present 
sacrifice of animals.before five hours only if they 
were near death; the Pohorecky study selected animals only on the basis 
of time after endotoxin injection. If "time- and dose- dependence" is 
interpreted as the severity of shock, the results of both studies are in 
agreement. 
Tissue epinephrine content was also measured in the present 
experiments. In many cases epinephrine data was not reported because of 
the limitations of the measurement. According to Crout (29), 
quantitative significance should only be ascribed to epinephrine values 
when they exceed 5% of the calculated norepinephrine content. 
Phenylethanolamine-N-methyl transferase (PNMT), the enzyme responsible 
for conversion of norepinephrine to epinephrine, has been found 
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primarily in the adrenal medulla (8) and to a small extent in the 
central nervous system (5,22,119). Low levels of epinephrine-forming 
activity have even been demonstrated in hearts of rabbits although the 
physiologic significance of it remains questionable (5). Therefore, 
epinephrine is 
tissues, although 
not readily synthesized 
they generally contain 
in non-adrenal peripheral 
small amounts of it. The 
origin of peripheral tissue epinephrine is most likely from circulating 
epinephrine that is recovered by the neuronal uptake process, Uptake 1 
(76). Thus, the amount of epinephrine in a peripheral tissue is 
dependent upon the synthesis of epinephrine in the tissue, the 
circulating concentration of epinephrine in the blood, the blood flow to 
the tissue, the rate of neuronal uptake, and the extent of degradation 
of the amine inside the nerve terminal. Therefore, interpretation of 
peripheral tissue epinephrine content must be made with the above 
considerations in mind. 
Cardiac epinephrine content increased during endotoxicosis 
(Table III). However, it is important to note that only 5 of 15 
epinephrine values of control samples were used in the analysis while 21 
of 21 endotoxic samples were included. The necessity to delete 
epinephrine 
norepinephrine 
selected for 
values that were less than 5% of the corresponding 
values may have introduced a sampling error by having 
data with abnormally high epinephrine to norepinephrine 
ratios. Therefore, saline control epinephrine content may be skewed to 
the high end of normal. This effect would minimize observed increases 
in epinephrine content during endotoxicosis. A significant increase was 
166 
noted, however, during shock and is considered a real change, although 
the quantitative significance or the control data must be qualified. 
Similarly, increased epinephrine content in peripheral non-adrenal 
tissue has been reported previously in hemorrhagic models (23,52,55). 
During endotoxin shock in the dog, a tendency toward increased 
epinephrine content 
demonstrated, but the 
contols (164). In 
catecholamines during 
in hearts, 
results were 
light of the 
endotoxicosis, 
livers, and spleens has been 
not statistically different from 
evidence for 
it is likely 
elevated plasma 
that circulating 
epinephrine was taken up by cardiac sympathetic nerve endings and 
subsequently stored there. The present experiments that demonstrated 
uncompromised neuronal reuptake in the myocardium also support this 
hypothesis. 
B. Characterization of Norepinephrine Depletion 
One consistent finding in the initial experimental series was 
the relationship between norepinephrine content and plasma glucose 
during endotoxicosis (see Figures 11 and 12). Classic views support the 
thesis that activation of the sympathoadrenal system during fasting or 
hypoglycemic states plays a role in maintaining metabolic substrate 
homeostasis (15,48,94). Another view has been championed recently by 
Landsberg 
in various 
the same 
and Young who demonstrated decreased norepinephrine turnovers 
peripheral organs during fasting and increased turnovers in 
organs during feeding and overfeeding (3,89,163). Adrenal 
medullary function (assessed by plasma epinephrine concentrations), 
however, was shown to more 
traditional theories (90,162). 
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closely approximate results expected by 
Despite the conflicting theories, it was 
reasonable to question whether the norepinephrine depletion associated 
with endotoxic shock was solely a function of decreased plasma glucose 
concentration. The singular role of hypoglycemia on heart and spleen 
norepinephrine content was assessed in a separate model of insulin 
hypoglycemia. Tissue samples were collected 90 minutes after 
intravenous injection of various doses of regular insulin. This 
particular regimen was 
glucose of endotoxic 
hypoglycemic endotoxic 
developed to mimic the variable fall in plasma 
rats. Additionally, because most of the 
rats were sacrificed from 3 to 5 hours 
post-injection, and because rats first experience a hyperglycemic phase 
before hypoglycemia, a 90 minute falling phase in plasma glucose (in the 
insulin group) is a reasonable parallel to the endotoxic state. The 
data indicated that insulin hypoglycemic rats did not display the 
norepinephrine depletion characteristic of endotoxicosis (Table IV). In 
similar fashion, regression analysis of tissue norepinephrine versus 
plasma glucose for insulin hypoglycemic rats failed to reveal a 
significant correlation (Figures 14 and 15). Lastly, neither the mild 
nor severe insulin hypoglycemic group displayed cardiac or splenic 
norepinephrine content significantly lower than saline controls. The 
results obtained do not preclude norepinephrine depletion in other, more 
severe (either lower plasma glucose or longer maintenance of 
hypoglycemia) models of insulin hypoglycemia. Thus, the conclusion of 
the experiments is that, in the model of insulin hypoglycemia employed, 
norepinephrine metabolism in peripheral tissues was not adversely 
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affected. Revealing experiments to be pursued in this area are: 1) 
tissue norepinephrine measurement during prolonged hypoglycemia to test 
the effect of the severity of the stress, and 2) measurement of 
norepinephrine turnovers in a prolonged model of insulin hypoglycemia 
(perhaps using longer acting lente and ultra-lente insulins). The 
latter experiments would reveal whether conditions for norepinephrine 
depletion were present (increased sympathetic activity) and would also 
provide a different situation (high insulin and low plasma glucose) for 
investigation of the Landsberg and Young hypothesis (when feeding or 
fasting induced physiologic parallel changes in plasma glucose and 
insulin). 
Cardiac epinephrine content 
hypoglycemia. During hypoglycemia 
ratio was generally high enough 
was also measured during insulin 
the epinephrine to norepinephrine 
so that 37 of 41 samples met the 
criteria for epinephrine quantitation. Mean epinephrine content of the 
myocardium was increased during insulin hypoglycemia and was found to be 
inversely correlated with the plasma glucose concentration. These 
results are consistent with the interpretation that adrenal medullary 
secretion of epinephrine into the circulation was increased during the 
hypoglycemia, augmenting circulating levels of catecholamines, and 
thereby increasing uptake of amines into peripheral sympathetic nerve 
endings. 
Fine and associates demonstrated in the dog that abdominal 
denervation protected against the lethality and splanchnic 
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histopathologic changes associated with endotoxic shock (114,165). The 
denervation also prevented the norepinephine depletion of the abdominal 
organs (165). Their conclusion that norepinephrine depletion was 
dependent upon neural drive was confirmed in the present experiments: 
Treatment of rats with the ganglionic blocker, chlorisondamine, 
prevented norepinephrine depletion in the heart during endotoxicosis 
(Figure 17). Because nerve section or blockade, as well as ganglionic 
blockade eliminated norepinephrine depletion, endotoxin probably did not 
directly cause release of norepinephrine. If endotoxin or its mediators 
directly elicited release of norepinephrine, the depletion would have 
occurred in the absence of neural activity. 
Experiments other than the denervation studies of Fine have 
implicated the sympathetic nervous system in the pathogenesis of 
endotoxic shock. Abundant literature has been cited that documents the 
beneficial effects of alpha adrenergic blockade during endotoxicosis 
(10,57,58,96). One report also demonstrated that beta adrenergic 
blockade sensitized rats to endotoxic hypoglycemia and lethality. Based 
on the literature two questions become apparent: 1) Do interventions 
that protect against endotoxic shock (e.g. alpha adrenergic blockade) 
also protect against norepinephrine depletion, and vice versa (i.e. the 
effects of beta antagonist sensitization on tissue norepinephrine 
content)? 2) Does prior depletion of norepinephrine stores and hence 
decreased adrenergic stimulation by peripheral sympathectomy protect 
against endotoxic shock? Both questions were investigated. 
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Filkins has reported (46) that intraperitoneal pretreatment of 
rats with propranolol, a nonselective beta adrenergic antagonist, 
sensitized rats to lethality associated with endotoxic shock and that 
the animals also displayed compromised glucose homeostatic capability 
(depressed hepatic gluconeogenesis and hypoglycemia). Opposite results 
were found after alpha adrenergic blockade pretreatment with 
phentolamine. A similar model was employed in the present studies, 
although the dose of endotoxin administered to beta-blocked rats was 
higher (5 mg/300 gm rat) than in the previous study (3 mg/300 gm rat). 
Results confirmed the change in lethality with adrenergic blockade: all 
alpha adrenergic blockade rats survived the 5 hour protocol and all beta 
adrenergic blocked rats died within 30 minutes of endotoxin injection 
(mean time to death was 18 + 1 minutes). Phentolamine pretreated rats 
had higher plasma glucose levels than rats administered endotoxin alone. 
However, no statistical decreases in plasma glucose of 
propranolol-treated rats was evident. This may be explained by the 
increased endotoxin dose employed in the propranolol rats. Death may 
have been caused by acutely fulminating cardiovascular or pulmonary 
changes (early systemic hypotension and pulmonary hypertension are 
common complications of endotoxicosis) that were not compensated for by 
a myocardium unresponsive to beta adrenergic stimulation. Thus, the 
late metabolic changes were not yet evident at the time of death 
(evidenced by fairly normal plasma glucose levels). In similar fashion, 
no depletion of tissue norepinephrine was seen in propranolol-treated 
rats. Again, the time to death may have been too short to observe any 
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changes. However, in phentolamine rats, cardiac and splenic 
norepinephrine content was greater at 5 hours than rats treated with 
endotoxin alone. It can be concluded that phentolamine protection 
during endotoxicosis is also associated with a tissue norpinephrine 
It is impossible, however, to determine whether, in the sparing effect. 
alpha-blocked rat, the improved glucose homeostasis, improved perfusion 
organs, or some direct effect of phentolamine to decrease of various 
sympathetic drive was responsible for the improved tissue norepinephrine 
levels. 
As reviewed earlier, various forms of total peripheral 
sympathectomy have been investigated during endotoxin shock (2,9,58,99). 
Chemical sympathectomy with either guanethidine, bretylium tosylate, or 
6-hydroxydopamine, was not shown to have a protective effect in newborn 
rats (2). However, sympathectomy with 6-hydroxydopamine did protect 
against lethality and fibrin deposition in rabbits (9). Reserpine 
pretreatment also significantly depleted tissue norepinephrine content 
and protected against endotoxin lethality in rabbits and mice (58). 
Finally, epidural spinal block sensitized dogs to endotoxic lethality 
(99). Despite the contradictory results, experiments in 
sympathectomized rats were performed for the following reasons: 1) The 
studies on newborn rats were conducted so early after birth that normal 
sympathetic reflexes in the control, non-sympathectomized rats may not 
yet have been developed enough to affect the shock state (54). 2) 
Studies that utilized spinal epidural anesthesia were simply not 
specific for ablation of only the sympathetic nervous system. All 
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descending spinal pathways were interrupted, causing stress and trauma 
independent of the endotoxic insult. 3) The phentolamine protection and 
propranolol sensitization experiments of this study suggested an 
intriguing concept. Chemical sympathectomy with 6-hydroxydopamine 
eliminates peripheral norepinephrine stores but leaves the adrenal 
medulla intact (containing an epinephrine/norepinephrine mixture) (146). 
In a very nonspecific way, sympathectomy eliminates much of the alpha 
adrenergic dominant norepinephrine and leaves much of the beta 
adrenergic epinephrine intact. Thus, sympathectomy, while drastically 
reducing sympathetic tone, also to some extent is weighted toward 
minimizing "alpha" tone and not affecting "beta" tone a functional 
alpha blockade with minimal beta blockade. Chemical sympathectomy in 
the present model with 6-hydroxydopamine significantly decreased 
endotoxic lethality from 6 hours after endotoxin through the end of the 
24 hour protocol. Post-mortem examination revealed qualitatively that 
mesenteric lesions were less severe in the sympathectomized rats. The 
lethality data is consistent with similar experiments of Bolton and Atuk 
(9) in the rabbit, and of Gourzis, Hollenberg, and Nickerson in the 
rabbit and mouse (58). These data indicated that this form of blunted 
sympathetic activity was also protective in the endotoxic rat. Further 
evaluation of metabolic parameters in the sympathectomized rat model may 
be important to elucidate any protective effects on glucose or fat 
metabolism. 
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C. Norepinephrine Reuptake in Endotoxic Shock 
The experiments described thus far, have shown norepinephrine 
depletion to be associated with the severity of shock as assessed by 
plasma glucose concentrations, and to be dependent on neural drive. As 
Figure illustrates, a constant tissue content of norepinephrine is 
dependent on an equilibrium between processes that increase the pool 
size (biosynthesis and neuronal reuptake) and that decrease it 
(sympathetic activity and intraneuronal degradation). The depletion of 
norepinephrine from tissues during endotoxic shock must result from the 
disturbance of one or more of the above described processes. Because 
the depletion is dependent on release of norepinephrine, and because 
reuptake 
synaptic 
depletion 
is responsible for conservation of transmitter present in the 
cleft, decreased reuptake may contribute to norepinephrine 
from nerve terminals. Indeed, Bhagat and Friedman (6) have 
stressed the importance of neuronal reuptake in maintaining pool size 
during conditions of high sympathetic tone. Additional previous 
observations during endotoxic shock are consistent vith this hypothesis. 
Depressed reuptake would result in more release of catecholamines into 
the general circulation, a finding well-documented by increased 
concentrations of circulating catecholamines in endotoxicosis. Because 
reuptake also is the main mechanism for termination of transmitter 
action, a decrease in this process would intensify sympathetic-mediated 
responses. Increased vascular sensitivity to epinephrine has been shown 
after endotoxin administration (58,167), although conflicting results 
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have been reported (104). However, the demonstration that vasodilators 
protected against endotoxic shock (10,57,58,96) indicated that 
adrenergic vasoconstriction of the peripheral circulation was high 
during shock. Thus, adequate evidence has implicated depressed neuronal 
reuptake of norepinephrine in the norepinephrine depletion of endotoxin 
shock. 
The present experiments were designed to evaluate whether 
depression of neuronal reuptake of norepinephrine occurred during 
endotoxic shock. Initial experiments assessed norepinephrine uptake by 
measuring the amount of injected 3H-norepinephrine taken up and stored 
by hearts and spleens. Previous studies have been conducted that 
utilized similar protocols in the rat (120) and dog (123). These 
experiments have already been reviewed in detail, but the differences in 
methodology from the present work need to be stressed. Pohorecky et al. 
(120) described increased norepinephrine reuptake measured in vivo early 
after endotoxin administration. The methods were similar to those used 
in the present study. However, the measurement was made only one hour 
after endotoxin injection shorter than in the present experiments. 
.Also, in the Pohorecky study the endotoxin was administered 
intraperitoneally and not intravenously. The demonstration of increased 
reuptake may be due to the model employed or to elevated plasma 
catecholamine levels that are associated with endotoxicosis. 
Observations have been made that indicate increased norepinephrine 
reuptake during periods 
concentrations are high 
of high 
( 17 '50). 
sympathetic activity when substrate 
The Rao et al. investigafion (123) 
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also assessed norepinephrine reuptake in vivo by measuring the 
incorporation of radiolabeled norepinephrine into endogenous stores. 
However, the time between tracer injection and tissue sampling was too 
long (150 minutes) to ascribe the results to solely norepinephrne 
reuptake. 
Both of the aforementioned studies (120,123), as well as the 
present experiments, utilized the alumina chromatography method for 
isolation of catecholamines before counting the samples for 
3H-norepinephrine. However, the alumina chromatography technique does 
not eliminate the deaminated metabolite, 3,4-dihydroxyphenylglycol 
(DOPEG) (59). DOPEG has been shown to be a substantial fraction of the 
3H released from various tissues after loading of the tissues with 
3H-norepinephrine (59,91 ,144,145). Therefore, it is reasonable that in 
any of the studies in question, DOPEG may have, in part, been measured 
in the eluate after alumina chromatography. However, the interest is in 
the catecholamines retained within the tissue and not released from it. 
The following studies have 
previously loaded with 
reported on experiments 
3H-norepinephrine that 
with tissues 
have measured 
norepinephrine and its metabolites that were retained in, as well as 
released from the tissues (19,59,145). 
Graefe et al. (59) measured the radioactivity spontaneously 
released from and retained in isolated, rat vas deferens preparations 
perfused with 3H-norepinephrine. Norepinephrine and its metabolites 
were separated by alumina chromatography followed by a Dowex 50Wx4 
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column (to separate norepinephrine from DOPEG). The spontaneous outflow 
of 'H-catechols from the preparation was measured two hours after the 
end of incubation with 3H-norepinephrine. Results indicated that 70% of 
3H released spontaneously from the isolated, perfused organ was in the 
However, at the same time after incubation, 
3H-norepinephrine accounted for over 95% of the total radioactivity 
retained within the tissue. In similar fashion, Tarlov and Langer (145) 
investigated the effect of field stimulation on the release of labeled 
norepinephrine from rat and guinea pig atria. Norepinephrine and its 
metabolites were separated by paper chromatography. Results indicated 
that 90% of the radioactivity released spontaneously from atria was 
associated with norepinephrine metabolites primarily deaminated 
byproducts (including DOPEG). Field stimulation increased the release 
of radioactivity and also the fraction of 3H recovered as 
3H-norepinephrine (60% norepinephrine and 40% deaminated metabolites). 
Analysis of the radioactivity retained within atria 150 minutes after 
the end of incubation with 3H-norepinephrine demonstrated that more than 
90% of the radioactivity corresponded to the norepinephrine 
chromatographic peak. Similar results have been demonstrated in 
isolated canine hearts (19). 
Therefore, the present and cited studies which assessed 
norepinephrine reuptake during endotoxicosis with 3H-norepinephrine and 
alumina column chromatography have assurance from related studies that 
the measured radioactivity was associated with norepinephrine rather 
than its metabolites. It should also be noted that even if the 
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recovered 'H-norepinephrine was metabolized prior to measurement, the 
total radioactivity would still be an accurate measure or uptake since 
the metabolism occurred after reuptake. Had metabolism of 
norepinephrine occurred before reuptake, the byproducts would have been 
o-methylated extraneuronally by COMT. Uptake 1 will not transport 
amines with methoxyl groups present on the aromatic ring (76). The 
results of the present in vivo experiments (Tables VII and VIII) 
indicated that norepinephrine reuptake was depressed in spleens, but not 
in hearts of endotoxic rats. The depression of reuptake in the spleen 
was directly related to the severity of the shock state. Experiments in 
this study have already demonstrated that norepinephrine depletion from 
the heart and spleen was also related to the severity of the shock 
state. Although the present experiments indicated that the spleen 
functionally takes up less norepinephrine in endotoxicosis, the results 
may be reasonably interpreted in two ways: 1) reuptake was depressed in 
nerve endings of the spleen, and 2) during endoxicosis, blood flow was 
shunted away from the spleen, and hence less delivery of labeled 
norepinephrine to the spleen occurred. 
Support for the latter hypothesis is present in existing 
literature. Measurements of blood flow distribution in various 
endotoxic models indicated that while the per cent of cardiac output to 
the myocardium remained unaltered or elevated, the proportion to 
splanchnic organs was severely limited (42,83,159,160). In the 
unanesthetized monkey, Wyler et al. (159) used radiolabeled microspheres 
to measure cardiac output distribution both acutely (at the end of a 40 
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minute infusion period) and 24 hours after E. ~ endotoxin infusion. 
Acutely, all vascular beds demonstrated some degree of vasodilatation 
except the spleen, in which vascular resistance tripled, and blood flow 
decreased from 134 to 24 ml/(min x 100 gm tissue). At the same time, 
coronary resistance fell, and total coronary flow actually increased to 
142 ml/(min x 100 gm) compared to saline-injected, time-matched, 
controls (98 ml/(min x 100 gm)). Twenty-four hours after endotoxin 
infusion, results from heart and spleen were essentially the same: 
directional changes in vascular resistance compared to time-matched 
controls were the same, but the magnitude of the responses were reduced. 
The same group of investigators (160) studied the distribution of 
cardiac output in unanesthetized endotoxic rabbits using similar 
techniques. Measurements were made O, 60, and 150 minutes after 
endotoxin injection. Vascular resistance increased most dramatically in 
the spleen, kidneys, and skin of endotoxic rabbits compared to 
time-matched controls. Vasoconstriction in the coronary circulation was 
minimal during endotoxicosis and often was no different from 
time-matched control values. 
Blood flow measurement using radiolabeled microspheres has also 
been applied to rodent models. Ferguson et al. (42) measured regional 
blood flow in the unanesthetized endotoxic guinea pig. The percentage 
of cardiac output to the spleen was drastically reduced at both one and 
three hours after endtoxin injection. The coronary circulation received 
a higher proportion of the cardiac output during endotoxicosis. 
However, since cardiac output fell, both organs had lover than control 
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flow after endotoxin, but the flow deprivation to the spleen was much 
greater than to the myocardium. In the rat, Keeler et al. {83) used two 
slow infusions of endotoxin {10 mg/kg over 4 hours; 2.5 to 3 mg/kg 
infused over a period of four days) to more closely simulate a septic 
state. The acute (4 hour) infusion was lethal to 64% of the rats; 
chronic infusion (4 days) resulted in no lethality. Under anesthesia, 
cardiac output and its distribuion were measured using radioactive 
microspheres. Cardiac output was reduced in both acute and chronic 
models of endotoxicosis, although the reduction was greatest in the 
acute situation. The per cent of cardiac output to the myocardium 
remained unchanged in both acute and chronic endotoxicosis compared to 
control. Percentage distribution of cardiac output to liver, 
gastrointestinal tract, and skin fell in both models of endotoxemia. 
Although spleen flows were not measured, hepatic and gastrointestinal 
data may be examined as representative of abdominal organ responses. 
Thus, distribution of cardiac output during endotoxicosis has 
been shown to consistently decrease in the spleen, but may not change or 
actually increase in the heart. Labeled norepinephrine uptake from the 
circulation is especially sensitive to blood flow distribution to 
various organs. In the present experiments norepinephrine reuptake 
assessment was dependent on circulatory distribution; thus the decreased 
amount of labeled norepinephrine found in the spleen may have been the 
result of decreased distribution of flow to that region. Because flow 
distribution changes little in the myocardium, results in that organ may 
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be more representative of the actual uptake process rather than a 
function of delivery. 
Therefore, experiments were undertaken to study norepinephrine 
reuptake in a model where delivery of the labeled bioamine was not 
flow-limited. Incubation of tissue slices in vitro effectively 
controlled substrate availability to the reuptake sites. It also 
ensured that both control and endotoxic preparations were oxygenated to 
the same extent. Results of in vitro experiments indicated similar 
findings as the in vivo studies: norepinephrine reuptake and retention 
was depressed in spleen slices but not myocardial slices from endotoxic 
rats (Figures 19 and 21). Because spleen vet weight increased during 
endotoxicosis and results were based on a wet weight basis, the 
norepinephrine retention values were corrected to eliminate the possible 
error. After correction, spleen slices from endotoxic rats still 
retained far less norepinephrine than spleen slices from controls. The 
differential depression of norepinephrine uptake between organs raises a 
question regarding the mechanism responsible for it. If endotoxin or 
its mediators were responsible for reuptake inhibition, the effect 
should have been evident in both hearts and spleens. However, because 
neuronal reuptake of norepinephrine is energy dependent (76), and 
because blood flow is severely reduced to the spleen (but not the heart) 
during endotoxicosis (42,83,159,160), reuptake depression in the spleen 
may have been caused by flow and hence energy deprivation secondary to 
endotoxin administration. The ischemia and acidosis in the spleen was 
probably more severe in the latter stages of shock, which is.also the 
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time when norepinephrine uptake was most severely limited in the in vivo 
experiments. 
Another energy dependent process associated with monoamine 
metabolism is the uptake of norepinephrine from neuronal cytoplasm into 
vesicles. Because neuronal reuptake has been compromised, it is 
reasonable to assume that the repackaging process bas also been 
affected. Neuronal reuptake without concomitant revesicularization 
results in degradation of the norepinephrine by monoamine oxidase. 
Thus, if repackaging was depressed, much of the norepinephrine taken up 
by the reuptake process would be reduced to metabolites. The data in 
Figure 23 illustrate that relatively more of the norepinephrine taken up 
by spleen slices of control rats remained urunetabolized than in the 
spleens of severely shocked rats. Thus, these results suggest that 
increased intraneuronal degradation occurred in spleens of endotoxic 
rats, which may contribute to the norepinephrine depletion that occurs 
in that organ. Experiments on endotoxic guinea pigs (7) also provided 
evidence consistent with this hypothesis. 
D. Norepinephrine Turnovers during Endotoxicosis 
Norepinephrine turnovers accurately reflect the level of 
sympathetic nerve activity (12,26,27) in various organs. Assessment may 
be made by any of the following methods: 1) Measurement of radiolabeled 
norepinephrine formed after infusion (111,133) or rapid inject~on (133) 
of radiolabeled tyrosine yields an accurate estimate of norepinephrine 
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synthesis and can be used to calculate turnover rates. 2) When 
norepinephrine synthesis is inhibited with alpha-methyltyrosine, 
endogenous norepinephrine levels decline at a rate proportional to the 
concentration of remaining amine. A graph of endogenous norepinephrine 
content versus time mathematically describes a first order relationship, 
and is used to calculate a rate constant of decay and a turnover rate 
(12,109). 3) Injection of labeled norepinephrine is taken up by 
sympathetic neurons and released along with endogenous norepinephrine. 
Under conditions of constant endogenous levels of norepinephrine the 
relationship of specific activity of tissue norepinephrine versus time 
describes a first order decay (105,26). 
Each technique has its positive aspects as well as its 
drawbacks. The labeled tyrosine methodology yields synthesis rates from 
single determinations while the other techniques necessitate use of 
groups of animals. However, the tyrosine method also relies on either 
an indwelling cannula or an acutely anesthetized animal model to 
facilitate infusion of tyrosine. The unanesthetized model would be of 
choice, but the possibility of stress and infection from prior surgery 
may complicate the endotoxin model. Additionally, methodology for 
analysis of tyrosine would be required. The alpha-methyltyrosine 
technique is reliable and can be performed in groups of unanesthetized 
animals, but the technique measures the decline in norepinephrine 
content over time. Because endotoxin administration alone can deplete 
norepinephrine from tissues, the first order decay of norepinephrine 
content induced by alpha-methyltyrosine injection may not occur during 
endotoxicosis. 
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The 3H-norepinephrine technique also depends on groups 
of animals to calculate a turnover rate. The method relies on constant 
levels of endogenous norepinephrine vhich may be a drawback during 
endotoxin shock. This methodology, however, does not by itself disturb 
the constancy of the endogenous norepinephrine content (which is not 
possible after alpha-methyltyrosine injection). However, the 
'H-norepinephrine technique was the procedure of choice to estimate 
sympathetic activity during endotoxicosis for the following reasons: 1) 
Low doses of endotoxin eliminated norepinephrine depletion as well as 
lethality. Furthermore, the constancy of the endogenous norepinephrine 
content was measured to ensure proper kinetic analysis. 2) Animals were 
studied in a non-invasive, unanesthetized model. 3) Sympathetic 
activity was assessed over a long period of time, rather than acutely 
during any short phase during endtoxicosis. 
Because the depletion of norepinephrine from peripheral organs 
was shown to be ·time- and dose-dependent (120), low dose endotoxin 
treatment (lethality was 5% at 24 hours) was used to minimize the 
depletion of norepinephrine. Preliminary experiments demonstrated that 
this regimen did not deplete norepinephrine from hearts or spleens. On 
occasion, however, tissue content of norepinephrine was drastically 
depressed in samples obtained 12 hours after endotoxin. These rats were 
probably more sensitive to endotoxin than others and were excluded from 
the study. Basal cardiac turnover rates in control animals are similar 
to those found in the literature, but tend to be on the slower end of 
those published (3,89,24). However, the experimental paradigm used in 
the present experiments may be responsible for this. The rats were 
housed singly for three days before the start of the turnover studies. 
Isolation may have an effect to lover sympathetic activity. 
Additionally, the rats were fasted for eighteen hours before and also 
during the turnover measurement. Fasting has been shown to decrease 
norepinephrine turnovers to various peripheral organs (89,90,163). 
Comparison of the present turnover rates with those of other studies 
that have also measured them in a fasting state show good similarity 
(3,89). 
Endotoxin treatment accelerated the turnover of norepinephrine 
in hearts and spleens of rats compared to controls (Figs. 24 and 25, 
Table XI). Thus, the average sympathetic activity to hearts and spleens 
of endotoxic rats was increased over the 12 hours after endotoxin 
injection. This conclusion is consistent with previous studies that 
used radiolabeled norepinephrine injections, although none of the 
investigations were designed to assess turnover rates quantitatively 
(16,120,123). While the results of the present experiments are also 
consistent with some electrophysiological results during endotoxicosis 
(61), they do not agree with the work of others (86,130). Halinen 
demonstrated increased cardiac sympathetic efferent nerve activity early 
after endotoxin injection in dogs (61). Koyama et al. (86) and 
Santiesteban et al. (130) demontrated decreased preganglionic splanchnic 
nerve activity in the endotoxic cat. Major differences in models and 
experimental design exist between the electrophysiological and turnover 
studies. The use of an invasive, anesthetized cat or dog model is 
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difficult to compare to the unanesthetized rat. Furthermore, the 
turnovers estimated nerve activity over a twelve hour period after 
endotoxin; nerve recording was performed for brief periods of time early 
after endotoxin. Additionally, the differences in species and endotoxin 
doses could easily have induced differential changes in sympathetic 
activity. 
Experiments of the present study demonstrated that 
norepinephrine reuptake was reduced in spleens of endotoxic rats in 
severe shock. Even though the low dose endotoxin injection for turnover 
measurement induced a modest lethality (5%) compared to the fundamental 
shock model (70% lethality), similar reuptake depression may have 
occurred. Depressed reuptake leads to a reduction of released 
transmitter that is recovered by the nerve terminal. It is possible 
that during turnover measurement in the spleen, reduced recovery of 
norepinephrine and 3H-norepinephrine caused an accelerated decay rate of 
norepinephrine specific activity, thus falsely indicating increased 
sympathetic nerve activity to that organ. This possibility was tested 
by treating control rats with a potent neuronal reuptake inhibitor, 
desmethylimipramine, before norepinephrine turnover measurement. The 
results indicated that the singular effect of decreased norepinephrine 
reuptake 
(Figures 
did not alter the fraction of norepinephrine released per hour 
26 and 27, Table XIII). Therefore, it is concluded that even 
if splenic norepinephrine reuptake was depressed in the present 
endotoxic model, it did not contribute to the observed increased rate of 
norepinephrine turnover. 
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The increased norepinephrine turnovers in hearts and spleens may 
have been the result of increased central drive of sympathetic nerves. 
However, electrophysiological experiments on isolated nerve-muscle 
preparations suggested that endotoxin affected information processing at 
the presynaptic site (115,117,118). One hypothesis was that endotoxin 
increased the amount of transmitter released per nerve impulse. If this 
indeed occurred in the in situ situation, norepinephrine turnovers may 
have increased without a concomitent increase in nerve activity. 
Alternatively, increased release per stimulus coupled with even a modest 
increase in sympathetic activity could result in greatly increased 
norepinephrine turnovers. The effect of increased norepinephrine 
release per 
norepinephrine 
stimulus would effectively accelerate the loss of 
from the existing pool (both labeled and unlabeled) and 
increase the replacement with newly formed unlabeled norepinephrine. 
Regardless 
hearts and 
magnified 
of the mechanism for the increased turnovers measured in 
spleens of endotoxic rats, the turnover rates may have been 
under conditions of higher endotoxin administration and 
contribute to the norepinephrine depletion that occurs in lethal 
endotoxic shock. 
E. Implications and Conclusions 
The role of the sympathetic nervous system in endotoxic shock is 
multi-faceted, and many of its aspects remain to be elucidated. 
Demonstrations of increased circulating concentrations and depleted 
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tissue content of catecholamines suggested that sympathetic activity was 
high during endotoxic shock. While a classic view of the sympathetic 
nervous system is that it aids in the maintenance of homeostasis during 
stressful or "fight or flight" situations, the sympathetic system may be 
a double edged sword in shock. Early during shock the sympathetic 
system may maintain blood presure and enhance metabolic substrate 
availability. However, the utilization of these compensatory mechanisms 
may exhaust both circulatory and metabolic reserve leading to the 
irreversible phase of shock. Presumably the vasoactive properties of 
catecholamines cause prolonged flow deficits to multiple organ systems, 
most notably the splanchnic region, to maintain perfusion of more flow 
sensitive areas such as heart and brain. Additionally, the metabolic 
effects of catecholamines may alter substrate availability as well as 
metabolism. Although the sympathetic nervous system may tide an animal 
through the early phases of shock, it may ultimately exacerbate the 
situation later in the form of ischemic organs and metabolic 
derangements. Many past reports as well as data presented here 
demonstrated the beneficial effects of reduced sympathetic stimulation 
during endotoxicosis. 
Norepinephrine depletion from peripheral tissues is one 
manifestation of sympathetic dysfunction during endotoxicosis that 
warrants further study. In light of increased plasma concentrations of 
catecholamines during shock, the depletion most likely represents a 
massive transfer of catecholamines from nerve terminals to synaptic 
spaces and finally to the general circulation. Thus, prevention of the 
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depletion would also prevent hyperactivation of adrenergic receptors. 
As discussed earlier, the major candidates for the mechanism of 
norepinephrine depletion were considered to be increased sympathetic 
activity and depressed neuronal reuptake. These hypotheses are 
consistent with the existing literature and also fit within the 
conceptual framework of sympathetic exacerbation of the shock syndrome. 
Increased sympathetic drive and decreased neuronal reuptake both result 
in greater release of catecholamines from nerve terminals. This is in 
contrast to hypotheses of singular inhibition of norepinephrine 
synthesis or increased intraneuronal degradation which would result in 
depletion, but not increased liberation of transmitter. 
Elucidation of the mechanism and subsequent prevention of the 
increased sympathetic activity as well as interventions to maintain 
splenic reuptake of norepinephrine may well be future goals to formulate 
protective interventions in not only endotoxic shock, but also its 
clinical counterpart, sepsis. 
SUMMARY 
Activation of the sympathetic nervous system during endotoxic 
shock has been demonstrated by a variety of methods: elevation of plasma 
catecholamines, depletion of tissue norepinephrine, altered disposition 
of administered radiolabeled catecholamines, and increased nerve 
activity measured directly by electrophysiological techniques. However, 
these studies have been largely indirect and/or contradictory in nature. 
Furthermore, a large volume of literature has implicated the sympathetic 
nervous system 
pathogenesis 
investigate 
of 
the 
either in a primary or secondary role - in the 
endotoxic shock. Experiments were designed to 
following aspects of sympathetic nervous system 
dysfunction during endotoxicosis in the white laboratory rat: 1) 
demonstrate and further characterize norepinephrine depletion from heart 
and spleen, 2) assess norepinephrine reuptake both in vivo and in vitro 
in hearts and spleens by measuring the amount of 3H-norepinephrine 
incorporated into those organs, and 3) quantitatively estimate the 
degree of sympathetic activity in both hearts and spleens of endotoxic 
rats by measurement of norepinephrine turnovers by the 3H-norepinephrine 
decay technique. 
Initial experiments demonstrated that the depletion from hearts 
and spleens was related to the severity of the shock state as evidenced 
by the significant negative correlation of norepinephrine content to the 
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plasma glucose concentration. A separate group of rats treated with 
insulin demonstrated no depletion and suggested that the depletion with 
endotoxin was not caused by the singular effect of low plasma glucose. 
Ganglionic blockade with chlorisondamine prevented the depletion from 
the heart (spleen was not tested) which provided evidence that the 
depletion was neurally-mediated. Alpha adrenergic blockade 
(phentolamine) before endotoxin injection significantly increased 
survival time, maintained normal plasma glucose levels, and resulted in 
higher cardiac and splenic norepinephrine content than in non-treated 
endotoxic rats. Beta adrenergic blockade (propranolol) before endotoxin 
injection significantly decreased survival time and exacerbated the 
hypoglycemia of endotoxicosis, but did not result in significant changes 
in cardiac or splenic norepinephrine content compared to non-treated 
endotoxic rats. Depletion of peripheral tissue norepinephrine content 
before endotoxin administration (sympathectomy with 6-hydroxydopamine) 
significantly decreased the lethality associated with endotoxin 
administration. 
Uptake of 3H-norepinephrine from the circulation was depressed 
in spleens, but not hearts of endotoxic rats (uptake depression was 
greater in spleens of severely shocked rats). Because blood flow 
distribution has been shown to change during endotoxicosis, in vitro 
experiments were repeated on hearts and spleens of control and severely 
shocked rats. Results of in vitro incubation of tissue slices with 
3H-norepinephrine were similar to in vivo results: uptake of labeled 
norepinephrine was depressed in spleens, but not hearts of endotoxic 
rats compared to control. 
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Additionally, less of the labeled 
norepinephrine was retained in its unmetabolized form in endotoxic 
spleens. The results indicated that reuptake depression may be a factor 
in the depletion of norepinephrine from spleens, but not hearts of 
endotoxic rats. Furthermore, uptake and degradation may also play a 
role in splenic norepinephrine depletion. 
Norepinephrine turnovers were increased in both hearts and 
spleens of rats administered a low dose of endotoxin (LD 5%). Turnovers 
were also measured in a group of rats injected with the norepinephrine 
reuptake blocker, desmethylimipramine to assess the singular role of 
reuptake inhibition on turnover rate. Comparison of turnover rates in 
control and desmethylimipramine-treated rats demonstrated no 
differences. Results indicated quantitatively that sympathetic activity 
was increased to hearts and spleen of endotoxic rats. 
It is concluded that norepinephrine depletion from hearts and 
spleens may be mediated by increased sympathetic activity to those 
organs. Additionally, decreased neuronal reuptake of norepinephrine may 
play a role in the norepinephrine depletion in the spleen, but not in 
the heart. Both mechanisms would result in increased stimulation of 
adrenergic receptors and contribute to the hypersympatheti~ state 
associated with the pathogenesis of endotoxic shock. 
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